Processing 00000000.tx.1: Thiol Activation of Endopeptidase EC 3.4.24.15 A NOVEL MECHANISM FOR THE REGULATION OF CATALYTIC ACTIVITY* (Received for publication, March 12,1997) Corie N. 

Phrase: "Thiol Activation of Endopeptidase EC 3.4.24.15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1879547:Activation [Activity]

Phrase: "A NOVEL MECHANISM FOR THE REGULATION OF CATALYTIC ACTIVITY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441712:Mechanism [Functional Concept]
   742   C1706376:Mechanism [Manufactured Object]

Phrase: "*"

Phrase: "("

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "March 12,"

Phrase: "1997"

Phrase: ")"

Phrase: "Corie N."
Processing 00000000.tx.2: Shrimpton , Marc J. 

Phrase: "Shrimpton ,"

Phrase: "Marc J."
Processing 00000000.tx.3: Glucksman , Rebecca A. 

Phrase: "Glucksman ,"

Phrase: "Rebecca A."
Processing 00000000.tx.4: Lew , John W. 

Phrase: "Lew , John W."
Processing 00000000.tx.5: Tullai , Elliott H. 

Phrase: "Tullai ,"

Phrase: "Elliott H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.6: Margulies , James L. 

Phrase: "Margulies ,"

Phrase: "James L."
Processing 00000000.tx.7: Roberts  and A. 

Phrase: "Roberts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.8: Ian Smith  From the Peptide Biology Laboratory, Baker Medical Research Institute, Prahran, Victoria 3181,Australia and the Dr. 

Phrase: "Ian Smith  From the Peptide Biology Laboratory,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0554249:Smith [Professional or Occupational Group]

Phrase: "Baker Medical Research Institute,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0035172:Research Institute [Organization]
   861   C0079816:Medical Research [Research Activity]
   861   C1556038:Medical Research [Professional or Occupational Group]
   812   C0021622:institute [Organization]
   812   C0035168:research [Research Activity]
   812   C0205476:Medical [Functional Concept]
   812   C0242481:Research [Research Activity]
   812   C1272753:Institute [Idea or Concept]

Phrase: "Prahran,"

Phrase: "Victoria 3181,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042645:Victoria [Geographic Area]
   861   C0997115:Victoria [Plant]

Phrase: "Australia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]

Phrase: "and"

Phrase: "the Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.9: Arthur M.

Phrase: "Arthur M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.10: Fishberg Research Center for Neurobiology, Mount Sinai School of Medicine, NewYork,NewYork10029 ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION FOOTNOTES ACKNOWLEDGEMENTS REFERENCES ABSTRACT Endopeptidase EC 3.4.24.15 (EP24.15) is a thermolysin-like metalloendopeptidase involved in the regulated metabolism of a number of neuropeptides. 

Phrase: "Fishberg Research Center for Neurobiology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0683939:research center [Manufactured Object,Organization]
   760   C0205099:Center [Spatial Concept]

Phrase: "Mount Sinai School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "NewYork,"

Phrase: "NewYork10029 ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION FOOTNOTES ACKNOWLEDGEMENTS"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "ABSTRACT Endopeptidase EC 3.4.24.15 (EP24.15)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   911   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   829   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0000857:Abstract [Occupational Activity]
   795   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   795   C0600678:Abstract [Intellectual Product]
   795   C1552863:Abstract [Idea or Concept]

Phrase: "is"

Phrase: "a thermolysin-like metalloendopeptidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Thermolysin-Like Metalloendopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1442934:Metalloendopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "involved in the regulated metabolism of a number of neuropeptides."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0025519:Metabolism [Organism Function]
   739   C0025520:metabolism [Functional Concept]
   739   C0027895:Neuropeptides [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   739   C0237753:*Number [Quantitative Concept]
   739   C0449788:Number [Quantitative Concept]
   739   C0851285:Regulated [Governmental or Regulatory Activity]
   739   C1314939:Involved [Functional Concept]
Processing 00000000.tx.11: Unlike other thermolysin-like peptidases EP24.15 displays a unique thiol activation, a mechanism that is not clearly understood. 

Phrase: "Unlike other thermolysin-like peptidases EP24.15"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   875   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   858   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   817   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   807   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0030940:Peptidases [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   791   C0039815:Thermolysin [Amino Acid, Peptide, or Protein,Enzyme]
   758 E C1947941:Peptidase [Enzyme]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a unique thiol activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "is"

Phrase: "not clearly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "understood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]
Processing 00000000.tx.12: In this study we show that both recombinant and tissue-derived EP24.15 are activated up to 8-fold by low concentrations (0.1mM) of dithiothreitol. 

Phrase: "In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "both recombinant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514798:recombinant [Organism]

Phrase: "and"

Phrase: "tissue-derived EP24.15"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   890   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   869   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   822   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   793   C0040300:Tissue [Tissue]
   793   C1441547:Derived [Qualitative Concept]
   793   C1547928:Tissue [Intellectual Product]
   793   C3245521:derived [Idea or Concept]

Phrase: "are"

Phrase: "activated up to 8-fold"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0332462:Fold [Spatial Concept]
   760   C1879547:Activated [Activity]
   760   C1880834:FOLD [Phenomenon or Process]
   726 E C1515877:Activate [Functional Concept]

Phrase: "by low concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(0.1mM"

Phrase: ")"

Phrase: "of dithiothreitol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.13: Additionally, under non-reducing conditions, recombinant and native EP24.15 forms multimers that can be returned to the monomeric form by reduction. 

Phrase: "Additionally,"

Phrase: "under non-reducing conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "recombinant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514798:recombinant [Organism]

Phrase: "and"

Phrase: "native EP24.15 forms multimers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C1979934:Multimers [Chemical Viewed Structurally]
   708   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "returned to the monomeric form"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332156:Return to [Qualitative Concept]
           Return
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "by reduction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.14: We have also shown that competitive inhibitor binding occurs only to the monomeric form, which indicates that catalytic site access is restricted in the multimeric forms. 

Phrase: "We"

Phrase: "have"

Phrase: "also"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that competitive inhibitor binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0005458:Binding, Competitive [Molecular Function]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "only to the monomeric form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205171:Only [Quantitative Concept]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]
   760   C1720467:Only [Intellectual Product]

Phrase: "which"

Phrase: "indicates"

Phrase: "that catalytic site access"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0444454:Access [Spatial Concept]
   827   C1554204:access [Idea or Concept]
   734   C0205681:Catalytic Site [Functional Concept]
   734   C0600499:catalytic site [Amino Acid Sequence]

Phrase: "is"

Phrase: "restricted in the multimeric forms."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   760   C0443288:Restricted [Functional Concept]
   726 E C1522492:Form [Functional Concept]
Processing 00000000.tx.15: Through systematic site-directed mutagenesis we have identified that cysteine residues 246,253,and possibly 248are involved in the formation of these multimers. 

Phrase: "Through systematic site-directed mutagenesis"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   923   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   812   C0079866:Mutagenesis [Molecular Function]
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]
   812   C3146302:Mutagenesis [Laboratory Procedure]
   779   C0439851:Direct [Qualitative Concept]
   779   C1947931:Direct [Qualitative Concept]
   741 E C0439755:Directions [Spatial Concept]
   741 E C0449738:Direction [Spatial Concept]

Phrase: "we"

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "that cysteine residues 246,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "253,"

Phrase: "and"

Phrase: "possibly 248are"

Phrase: "involved in the formation of these multimers."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1314939:Involved [Functional Concept]
   748   C1522492:Formation [Functional Concept]
   748   C1979934:Multimers [Chemical Viewed Structurally]
Processing 00000000.tx.16: Furthermore, both a double mutant (C246S/C253S) and a triple mutant (C246S/C248S/C253S) are fully active in the absence of reducing agents, as measured by both inhibitor binding and hydrolysis. 

Phrase: "Furthermore,"

Phrase: "both"

Phrase: "a double mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(C246S/C253S"

Phrase: ")"

Phrase: "and"

Phrase: "a triple mutant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205174:Triple [Quantitative Concept]
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(C246S/C248S/C253S"

Phrase: ")"

Phrase: "are"

Phrase: "fully active in the absence of reducing agents,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205177:Active [Functional Concept]

Phrase: "as"

Phrase: "measured by both inhibitor binding"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0243122:binding [Functional Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1999216:Inhibitor [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "hydrolysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020291:Hydrolysis [Natural Phenomenon or Process]
Processing 00000000.tx.17: The formation and disruption of disulfide bonds involving these cysteine residues may be a mechanism by which EP24.15 activity is regulated through changes in intra- and extracellular redox potential. 

Phrase: "The formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "disruption of disulfide bonds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332453:Disruption [Functional Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "these cysteine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "a mechanism by which EP24.15 activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0441712:Mechanism [Functional Concept]
   738   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "regulated through changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in intra-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0347985:Intra [Temporal Concept]

Phrase: "and"

Phrase: "extracellular redox potential."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1709375:Redox Potential [Natural Phenomenon or Process]
   827   C0030012:Redox [Molecular Function]
   827   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.18: INTRODUCTION Endopeptidase EC 3.4.24.15 (EP24.15)1 is a 75-kDa neutral metalloendopeptidase that cleaves on the C terminus side of specific hydrophobic residues in substrates of less than 17amino acids (1, 2). 

Phrase: "INTRODUCTION Endopeptidase EC 3.4.24.15"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   829   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   795   C1293116:Introduction [Health Care Activity]
   795   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "(EP24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "is"

Phrase: "a 75-kDa neutral metalloendopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1442934:Metalloendopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "cleaves on the C terminus side of specific hydrophobic residues"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0205369:Specific [Qualitative Concept]
   739   C0441987:Side [Spatial Concept]
   739   C0598629:Hydrophobic [Qualitative Concept]
   739   C1552740:specific [Intellectual Product]
   706   C1709915:Residue [Conceptual Entity]
   706   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "in substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]

Phrase: "of less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "than 17amino acids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.19: EP24.15 is thought to be involved in the regulated metabolism of a number of neuropeptides including gonadotrophin-releasing hormone, bradykinin, and neurotensin and has more recently been implicated in the aberrant processing of the amyloid precursor protein in Alzheimer's disease (3, 4). 

Phrase: "EP24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in the regulated metabolism of a number of neuropeptides"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0025519:Metabolism [Organism Function]
   739   C0025520:metabolism [Functional Concept]
   739   C0027895:Neuropeptides [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   739   C0237753:*Number [Quantitative Concept]
   739   C0449788:Number [Quantitative Concept]
   739   C0851285:Regulated [Governmental or Regulatory Activity]
   739   C1314939:Involved [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "gonadotrophin-releasing hormone,"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
  1000   C0023610:Gonadotrophin releasing hormone [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   827   C0018061:Gonadotrophin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0019932:Hormone [Hormone]
   827   C1283071:Releasing [Functional Concept]
   827   C3536870:Gonadotropin [Pharmacologic Substance]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1963578:Release [Therapeutic or Preventive Procedure]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "bradykinin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006100:Bradykinin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1537501:bradykinin [Gene or Genome]

Phrase: "and"

Phrase: "neurotensin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1417869:NEUROTENSIN [Gene or Genome]

Phrase: "and"

Phrase: "has"

Phrase: "more recently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "implicated in the aberrant processing of the amyloid precursor protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0033666:protein processing [Molecular Function]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0443127:Aberrant [Qualitative Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1709634:Precursor [Idea or Concept]
   739   C1709694:Processing [Activity]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.20: EP24.15 is widely distributed in cells and tissues throughout the body, predominantly as a soluble form constituting about 80% of the total activity and as a minor membrane-associated form accounting for the remainder of the activity (5). 

Phrase: "EP24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "is"

Phrase: "widely"

Phrase: "distributed in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1704711:Distributed [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "tissues throughout the body,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C0040300:Body Tissues [Tissue]
           Tissues
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "predominantly as a soluble form constituting"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]

Phrase: "about 80%"

Phrase: "of the total activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and as a minor membrane-associated form accounting"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   744   C0000938:Accounting [Occupational Activity]
   744   C0025255:Membrane [Tissue]
   744   C0026193:Minor [Population Group]
   744   C0205165:Minor [Qualitative Concept]
   744   C0332281:Associated [Qualitative Concept]
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C0596901:Membrane [Cell Component]
   744   C1515981:And [Idea or Concept]
   744   C1522492:Form [Functional Concept]
   744   C1706182:Membrane [Manufactured Object]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for the remainder"

Phrase: "of the activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.21: High levels of EP24.15 activity have been localized, both catalytically and immunohistochemically, primarily to the brain, pituitary, and testis with lower levels in other tissues such as the liver, kidney, spleen, and lung (6). 

Phrase: "High levels of EP24.15 activity"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   757   C0683317:activity levels [Finding]
   741   C0456949:Level 3 [Intellectual Product]
   741   C0456950:Level 4 [Qualitative Concept]
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: ","

Phrase: "both catalytically"

Phrase: "and"

Phrase: "immunohistochemically,"

Phrase: "primarily to the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "pituitary,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032005:Pituitary, NOS [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "testis with lower levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0039597:Testis [Body Part, Organ, or Organ Component]
   770   C1278981:Testis [Body Part, Organ, or Organ Component]

Phrase: "in other tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "such as the liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "kidney,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "spleen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037993:Spleen [Body Part, Organ, or Organ Component]
  1000   C0771377:SPLEEN [Tissue]
  1000   C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "lung"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.22: Typical of metalloendopeptidases EP24.15 is inhibited by metal ion chelators and can be reactivated by divalent cations such as Zn2+ or Mn2+. 

Phrase: "Typical of metalloendopeptidases EP24.15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C3538928:Typical [Qualitative Concept]

Phrase: "is"

Phrase: "inhibited by metal ion chelators"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   781   C1881795:Metal Chelator [Pharmacologic Substance]
   781   C3537172:Metal Chelator [Pharmacologic Substance]
   760   C0007974:Chelators [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0022023:Ion [Element, Ion, or Isotope]
   760   C0025552:Metal [Inorganic Chemical]
   760   C0311403:Inhibited [Qualitative Concept]
   760   C1700702:ION [Functional Concept]
   726 E C1664784:Chelator [Eukaryote]

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "reactivated by divalent cations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0007448:Cations, Divalent [Chemical Viewed Structurally]
   770   C0007447:Cations [Chemical Viewed Structurally]
   770   C0521123:Reactivated [Functional Concept]

Phrase: "such as Zn2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346521:Zn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "or"

Phrase: "Mn2+."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347051:Mn2+ [Element, Ion, or Isotope,Inorganic Chemical]
Processing 00000000.tx.23: Like many of the thermolysin-like neutral metalloendopeptidases, the protein's active site contains a zinc ion, which participates in the catalytic process (7) and has the classical HEXXH motif (8) typical of zinc metalloproteases (9). 

Phrase: "Like many"

Phrase: "of the thermolysin-like neutral metalloendopeptidases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   912   C0025250:Thermolysin-Like Metalloendopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1442934:Metalloendopeptidases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the protein's active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0205681:Active Site [Functional Concept]
   827   C0205145:Site [Spatial Concept]
   827   C0205177:Active [Functional Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a zinc ion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022023:Ion [Element, Ion, or Isotope]
   861   C1700702:ION [Functional Concept]

Phrase: "which"

Phrase: "participates in the catalytic process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0007382:Catalytic [Natural Phenomenon or Process]
   760   C1184743:Process [Body Part, Organ, or Organ Component]
   760   C1522240:Process [Phenomenon or Process]

Phrase: "(7"

Phrase: ")"

Phrase: "and"

Phrase: "has"

Phrase: "the classical HEXXH motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "(8"

Phrase: ")"

Phrase: "typical of zinc metalloproteases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3538928:Typical [Qualitative Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.24: However, unlike the other thermolysin-like metallopeptidases such as angiotensin-converting enzyme, endothelin-converting enzyme, neutral endopeptidase, and the closely related endopeptidase EC 3.4.24.16 (EP24.16), EP24.15 displays a unique thiol activation. 

Phrase: "However,"

Phrase: "unlike the"

Phrase: "other thermolysin-like metallopeptidases such as angiotensin-converting enzyme,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0025543:Metallopeptidases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "endothelin-converting enzyme,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C2745878:endothelin-converting enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0079284:Endothelin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "neutral endopeptidase,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025250:Neutral Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:neutral endopeptidase [Gene or Genome]
   861   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1882074:Neutral [Qualitative Concept]
   861   C2825492:Neutral [Phenomenon or Process]

Phrase: "and"

Phrase: "the closely related endopeptidase EC 3.4.24.16 (EP24.16),"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   890   C0286406:endopeptidase 3.4.24.16 [Amino Acid, Peptide, or Protein,Enzyme]
           endopeptidase 24.16
   822   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   793   C0439849:Related [Qualitative Concept]
   793   C0445223:Related [Finding]
   721 E C0080103:Relation [Family Group]
   721 E C0869014:Relations [Social Behavior]

Phrase: "EP24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a unique thiol activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]
Processing 00000000.tx.25: EP24.15 is activated by low levels of thiol-containing reducing agents (<0.5 mM DTT) and inhibited by high concentrations (>5 mM DTT) (1, 10-12). 

Phrase: "EP24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "is"

Phrase: "activated by low levels of thiol-containing reducing agents"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   764   C0376446:Reducing Agents [Indicator, Reagent, or Diagnostic Aid]
   742   C0038734:thiol [Organic Chemical]
   742   C0205251:low [Qualitative Concept]
   742   C0332256:Containing [Functional Concept]
   742   C0392756:Reducing [Qualitative Concept]
   742   C0441889:Levels [Qualitative Concept]
   742   C1299352:Low [Qualitative Concept]
   742   C1550472:low [Idea or Concept]
   742   C1879547:Activated [Activity]
   742   C2700400:Containing [Activity]
   708   C0450442:Agent [Chemical Viewed Functionally]
   708 E C0456079:Level [Classification]
   708   C1254351:Agent [Pharmacologic Substance]
   708 E C1515877:Activate [Functional Concept]
   708   C1521826:Agent [Intellectual Product]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "("

Phrase: "<0.5 mM DTT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "inhibited by high concentrations"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0086045:Concentrations [Mental Process]
   770   C0205250:High [Qualitative Concept]
   770   C0311403:Inhibited [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "("

Phrase: ">5 mM DTT) (1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1418486:MM-1 [Gene or Genome]
   812   C0012789:DTT [Carbohydrate,Pharmacologic Substance]
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]

Phrase: "10-12"

Phrase: ")."
Processing 00000000.tx.26: Inhibition has been attributed to the disruption of intramolecular disulfide bridges (13) and to the thiophilicity of the catalytic zinc ion (14). 

Phrase: "Inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "attributed to the disruption of intramolecular disulfide bridges"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0012771:disulfide [Chemical Viewed Structurally]
   744   C0332453:Disruption [Functional Concept]
   744   C0456378:bridges [Medical Device]
   711   C0449234:Attribute [Idea or Concept]
   711   C1704772:Attribute [Conceptual Entity]
   711   C1882133:Attribute [Qualitative Concept]

Phrase: "(13"

Phrase: ")"

Phrase: "and to the thiophilicity of the catalytic zinc ion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0007382:Catalytic [Natural Phenomenon or Process]
   742   C0022023:Ion [Element, Ion, or Isotope]
   742   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   742   C1515981:And [Idea or Concept]
   742   C1700702:ION [Functional Concept]
   742   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.27: Despite the thiol-induced increase in EP24.15 activity, studies examining inhibition by thiol-blocking agents are somewhat ambiguous. 

Phrase: "Despite the thiol-induced increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:Increase [Functional Concept]

Phrase: "in EP24.15 activity,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   893   C1150171:endopeptidase activity [Molecular Function]
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]
   744   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "examining inhibition by thiol-blocking agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "are"

Phrase: "somewhat ambiguous."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1549102:Ambiguous [Organism Attribute]
   861   C3539086:Ambiguous [Intellectual Product]
   789 E C2346729:Ambiguity [Qualitative Concept]
Processing 00000000.tx.28: The specific and effective cysteine peptidase inhibitor E-64 was shown not to affect EP24.15 activity (12, 15), and partial inhibition was only observed at relatively high concentrations in a yeast homologue of EP24.15 (16). 

Phrase: "The specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "effective cysteine peptidase inhibitor E-64"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   839   C0070334:peptidase E [Amino Acid, Peptide, or Protein,Enzyme]
   839   C1418463:PEPTIDASE E [Gene or Genome]
   827   C2717970:Cysteine Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1280519:effective [Qualitative Concept]
   799   C1704419:Effective [Qualitative Concept]
   799   C1947941:Peptidase [Enzyme]
   799   C1999216:Inhibitor [Qualitative Concept]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "EP24.15 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   893   C1150171:endopeptidase activity [Molecular Function]
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]
   744   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(12,"

Phrase: "15"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "partial inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "was"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "observed at relatively high concentrations"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0086045:Concentrations [Mental Process]
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C2700149:HIGH [Intellectual Product]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "in a yeast homologue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1334043:Homologue [Gene or Genome]

Phrase: "of EP24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.29: Inhibition by thiol-modifying agents such as iodoacetate, iodoacetamide, and N-ethylmaleimide vary from virtually zero to 100%, and inhibition by these agents has been shown to be a time-dependent process (17). 

Phrase: "Inhibition by thiol-modifying agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "such as iodoacetate,"

Phrase: "iodoacetamide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021973:Iodoacetamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "N-ethylmaleimide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015101:N-Ethylmaleimide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Ethylmaleimide

Phrase: "vary from virtually"

Phrase: "zero to 100%,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0919414:Zero [Quantitative Concept]

Phrase: "and"

Phrase: "inhibition by these agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a time-dependent process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.30: Thus the precise mechanism(s) by which thiol-reactive agents modify the activity of EP24.15 remains unclear. 

Phrase: "Thus"

Phrase: "the precise mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "("

Phrase: "s) by which thiol-reactive agents"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0038734:thiol [Organic Chemical]
   753   C0205332:Reactive [Qualitative Concept]
   753   C2603362:S' [Clinical Attribute]
   719   C0450442:Agent [Chemical Viewed Functionally]
   719   C1254351:Agent [Pharmacologic Substance]
   719   C1521826:Agent [Intellectual Product]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the activity of EP24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C1150171:endopeptidase activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "remains"

Phrase: "unclear."
Processing 00000000.tx.31: The sequence of EP24.15 contains 14cysteine residues, 7of which are conserved in EP24.16, a closely related enzyme (18). 

Phrase: "The sequence of EP24.15"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C1519249:Sequence [Functional Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "14cysteine residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "7of"

Phrase: "which"

Phrase: "are"

Phrase: "conserved in EP24.16,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   855   C0286406:endopeptidase 3.4.24.16 [Amino Acid, Peptide, or Protein,Enzyme]
           endopeptidase 24.16
   770   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "a closely related enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.32: It has been suggested that cysteine residue 483,which lies 5 residues from the catalytic center, is responsible for the thiol dependence of EP24.15 (8). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that cysteine residue 483,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   755 E C1609982:Residual [Qualitative Concept]

Phrase: "which"

Phrase: "lies"

Phrase: "5 residues from the catalytic center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "is"

Phrase: "responsible for the thiol dependence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "of EP24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.33: However, this cysteine is also present in EP24.16, which is not activated by reducing agents, thus raising doubts as to its involvement. 

Phrase: "However,"

Phrase: "this cysteine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "also"

Phrase: "present in EP24.16,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   855   C0286406:endopeptidase 3.4.24.16 [Amino Acid, Peptide, or Protein,Enzyme]
           endopeptidase 24.16
   770   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0150312:Present [Quantitative Concept]
   744   C0449450:Present [Idea or Concept]

Phrase: "which"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "activated by reducing agents,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0376446:Reducing Agents [Indicator, Reagent, or Diagnostic Aid]
   770   C0392756:Reducing [Qualitative Concept]
   770   C1879547:Activated [Activity]
   737   C0450442:Agent [Chemical Viewed Functionally]
   737   C1254351:Agent [Pharmacologic Substance]
   737 E C1515877:Activate [Functional Concept]
   737   C1521826:Agent [Intellectual Product]

Phrase: "thus raising doubts as to its involvement."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0870444:doubts [Mental Process]
Processing 00000000.tx.34: The present studies were undertaken to determine the mechanism(s) by which EP24.15 is activated by thiols and to define the precise cysteine residue(s) involved. 

Phrase: "The present studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "undertaken"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "("

Phrase: "s) by which EP24.15"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   838   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   784   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   742   C2603362:S' [Clinical Attribute]

Phrase: "is"

Phrase: "activated by thiols"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0038734:Thiols [Organic Chemical]
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "the precise cysteine residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   755 E C1609982:Residual [Qualitative Concept]

Phrase: "("

Phrase: "s)"

Phrase: "involved."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]
Processing 00000000.tx.35: We have employed size exclusion chromatography and dynamic light scattering to examine EP24.15 in both a reduced and non-reduced state. 

Phrase: "We"

Phrase: "have"

Phrase: "employed size exclusion chromatography"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
   923   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C0456389:size [Spatial Concept]
   812   C0680251:EXCLUSION [Functional Concept]
   812   C2828389:Exclusion [Activity]
   712 E C0302647:chromatograph [Medical Device]

Phrase: "and"

Phrase: "dynamic light scattering to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C1882368:Dynamic Light Scattering [Laboratory Procedure]
   861   C0596837:Light Scattering [Phenomenon or Process]
   812   C0023693:Light [Natural Phenomenon or Process]
   812   C0439742:Scattering [Spatial Concept]
   812   C0729333:Dynamic [Functional Concept]
   812   C1306462:Light [Functional Concept]
   812   C1881376:Light [Qualitative Concept]

Phrase: "examine"

Phrase: "EP24.15 in both"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   855   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "a reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "and"

Phrase: "non-reduced state."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]
Processing 00000000.tx.36: We have also characterized the enzyme's ability to bind the specific inhibitor N-[1-(R,S)-carboxy-3-phenylpropyl]-Ala-Ala-Tyr-p-aminobenzoate (cFP) in the presence and absence of thiol reductants. 

Phrase: "We"

Phrase: "have"

Phrase: "also"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "the enzyme's ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the specific inhibitor N-[1-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1418824:INHIBITOR 1 [Gene or Genome]
   812   C0205369:Specific [Qualitative Concept]
   812   C1552740:specific [Intellectual Product]
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(R,S"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ")-"

Phrase: "carboxy-3-phenylpropyl"

Phrase: "]-Ala-Ala-Tyr-p-aminobenzoate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0000473:Aminobenzoate [Organic Chemical,Pharmacologic Substance,Vitamin]
   804   C0552314:Aminobenzoate [Organic Chemical,Pharmacologic Substance]

Phrase: "(cFP) in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0055162:CFP [Therapeutic or Preventive Procedure]
   770   C1418482:CFP [Gene or Genome]

Phrase: "and"

Phrase: "absence of thiol reductants."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.37: Finally, we have generated a series of EP24.15 mutant enzymes where each cysteine residue was systematically mutated to a serine and analyzed the properties of these mutants in the presence and absence of a reducing agent. 

Phrase: "Finally,"

Phrase: "we"

Phrase: "have"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "a series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "of EP24.15 mutant enzymes where"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C0014442:Enzymes [Enzyme,Organic Chemical]
   791   C0014445:enzymes [Functional Concept]
   708   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "each cysteine residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "was"

Phrase: "systematically"

Phrase: "mutated to a serine"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1705285:Mutated [Cell or Molecular Dysfunction]
   737 E C1513776:Mutate [Genetic Function]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the properties of these mutants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "absence of a reducing agent."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.38: Through these studies we have determined that EP24.15 forms intermolecular disulfide bridges involving Cys-246, Cys-248, and Cys-253 and that thiol activation of the enzyme occurs by the reduction of these low catalytic activity multimers to the more active monomeric form. 

Phrase: "Through these studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "determined"

Phrase: "that EP24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "intermolecular disulfide bridges"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012771:disulfide [Chemical Viewed Structurally]
   827   C0456378:bridges [Medical Device]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "Cys-246,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Cys-248,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Cys-253"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "that thiol activation of the enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0014429:Enzyme Activation [Molecular Function]
   753   C1879547:Activation [Activity]

Phrase: "occurs by the reduction of these low catalytic activity multimers"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   760   C0243102:catalytic activity [Molecular Function]
   760   C1264638:Catalytic activity [Functional Concept]
   760   C1547012:*Catalytic Activity [Quantitative Concept]
   757   C2267000:Reduction Activity [Molecular Function]
   739   C0007382:Catalytic [Natural Phenomenon or Process]
   739   C0205177:Activity [Functional Concept]
   739   C0205251:low [Qualitative Concept]
   739   C0301630:Reduction [Natural Phenomenon or Process]
   739   C0392756:Reduction [Qualitative Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441610:Reduction [Therapeutic or Preventive Procedure]
   739   C0441655:Activity [Activity]
   739   C1299352:Low [Qualitative Concept]
   739   C1550472:low [Idea or Concept]
   739   C1561536:*Activity [Idea or Concept]
   739   C1709305:Occur [Activity]
   739   C1979934:Multimers [Chemical Viewed Structurally]
   739   C2745955:OCCUR [Temporal Concept]

Phrase: "to the more active monomeric form."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0348078:Form [Qualitative Concept]
   812   C0376315:Form [Manufactured Object]
   812   C1522492:Form [Functional Concept]
Processing 00000000.tx.39: EXPERIMENTAL PROCEDURES Chemicals and Reagents The endopeptidase 24.15inhibitor cFP was synthesized (Dr. J.Boublik and L.Lakat) and iodinated (M.Fullerton) at the Baker Institute. 

Phrase: "EXPERIMENTAL PROCEDURES Chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0220806:Chemicals [Chemical]
   793 E C3272558:Chemical [Intellectual Product]

Phrase: "and"

Phrase: "Reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "The endopeptidase 24.15inhibitor cFP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0055162:CFP [Therapeutic or Preventive Procedure]
   812   C1418482:CFP [Gene or Genome]

Phrase: "was"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "(Dr. J.Boublik"

Phrase: "and"

Phrase: "L.Lakat"

Phrase: ")"

Phrase: "and"

Phrase: "iodinated"

Phrase: "("

Phrase: "M."

Phrase: "Fullerton"

Phrase: ")"

Phrase: "at the Baker Institute."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]
Processing 00000000.tx.40: The specific quenched fluorescent substrate (QFS), 7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-Pro-D-Lys-(2,4-dinitrophenyl), was synthesized by Auspep (Parkville, Victoria, Australia). 

Phrase: "The specific quenched fluorescent substrate (QFS),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1710236:Substrate [Manufactured Object]

Phrase: "7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   845   C0072136:Pro-Leu-Gly [Amino Acid, Peptide, or Protein]
   829   C0072142:Pro-Gly [Amino Acid, Peptide, or Protein]
   818   C0125601:Leu-Gly [Amino Acid, Peptide, or Protein]
   795   C0017890:Gly [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Pro-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2987124:PRO [Intellectual Product]

Phrase: "D-"

Phrase: "Lys-(2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024337:Lys [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "4-dinitrophenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "synthesized by Auspep"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1883254:Synthesized [Activity]

Phrase: "(Parkville,"

Phrase: "Victoria,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042645:Victoria [Geographic Area]
  1000   C0997115:Victoria [Plant]

Phrase: "Australia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]

Phrase: ")."
Processing 00000000.tx.41: DTT was purchased from Calbiochem (Alexandria, New South Wales, Australia). 

Phrase: "DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "purchased from Calbiochem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(Alexandria,"

Phrase: "New South Wales,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0027975:New South Wales [Geographic Area]
   827   C0043015:Wales [Geographic Area]
   827   C0205314:New [Temporal Concept]
   827   C1551837:Wales [Population Group]
   827   C1710133:South [Spatial Concept]

Phrase: "Australia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]

Phrase: ")."
Processing 00000000.tx.42: All other reagents were purchased from Sigma unless otherwise stated. 

Phrase: "All"

Phrase: "other reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "purchased from Sigma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]

Phrase: "unless"

Phrase: "otherwise"

Phrase: "stated."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1301808:stated [Geographic Area]
  1000   C1442792:Stated [Functional Concept]
   966 E C3148680:State [Geographic Area]
Processing 00000000.tx.43: EP24.15 Activity Assay Endopeptidase 24.15activity was assayed using a specific QFS, 7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-Pro-D-Lys-(2,4-dinitrophenyl), similar to that described by Tisljar et al. 

Phrase: "EP24.15 Activity Assay Endopeptidase 24.15activity"

Phrase: "was"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a specific QFS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1710236:Substrate [Manufactured Object]

Phrase: "7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   845   C0072136:Pro-Leu-Gly [Amino Acid, Peptide, or Protein]
   829   C0072142:Pro-Gly [Amino Acid, Peptide, or Protein]
   818   C0125601:Leu-Gly [Amino Acid, Peptide, or Protein]
   795   C0017890:Gly [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Pro-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2987124:PRO [Intellectual Product]

Phrase: "D-"

Phrase: "Lys-(2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024337:Lys [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "4-dinitrophenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "described by Tisljar et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.44: (19). 

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.45: Recombinant endopeptidase 24.15(0.5g) was assayed in duplicate in 2.5ml of 25mM Tris-buffered saline, pH 7.4,with or without 0.1mM DTT. 

Phrase: "Recombinant endopeptidase 24.15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C1514798:recombinant [Organism]

Phrase: "(0.5g"

Phrase: ")"

Phrase: "was"

Phrase: "assayed in duplicate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205173:Duplicate [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "in 2.5ml"

Phrase: "of 25mM Tris-buffered saline,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   844   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   812   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0036082:Saline [Substance]
   812   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   812   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "with"

Phrase: "or without 0.1mM DTT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0012789:DTT [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.46: Substrate (0.5mg/ml in dimethyl sulfoxide) was added to a final concentration of 4.5M, and the assay tubes were incubated at 37C for 30min. 

Phrase: "Substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "(0.5mg/ml in dimethyl sulfoxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "added to a final concentration of 4.5M,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0086045:Concentration [Mental Process]
   744   C0205088:Final [Temporal Concept]
   744   C1446561:Concentration [Quantitative Concept]
   744   C1524062:Added [Functional Concept]
   744   C1546485:Final [Idea or Concept]
   711 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "the assay tubes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0175730:tubes [Medical Device]
   861   C1547937:Tubes [Intellectual Product]
   861   C1704474:Tubes [Quantitative Concept]
   827 E C1561954:tube [Conceptual Entity]
   827 E C1704730:TUBE [Medical Device]

Phrase: "were"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 30min."
Processing 00000000.tx.47: The reactions were stopped by the addition of 25l of 100mM ZnCl2, and the tubes were cooled to room temperature. 

Phrase: "The reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "stopped by the addition of 25l of 100mM ZnCl2,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   742   C0078774:ZnCl2 [Hazardous or Poisonous Substance,Inorganic Chemical,Pharmacologic Substance]
   742   C1272691:stopped [Qualitative Concept]
   742   C1883712:Addition [Functional Concept]
   708 E C1947925:Stop [Activity]
   708 E C2746065:Stop [Temporal Concept]

Phrase: "and"

Phrase: "the tubes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0175730:tubes [Medical Device]
  1000   C1547937:Tubes [Intellectual Product]
  1000   C1704474:Tubes [Quantitative Concept]
   966 E C1561954:tube [Conceptual Entity]
   966 E C1704730:TUBE [Medical Device]

Phrase: "were"

Phrase: "cooled to room temperature."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1547703:Room [Spatial Concept]
   737   C1548792:Cool [Qualitative Concept]
Processing 00000000.tx.48: Fluorescence was read on a Perkin-Elmer LS-5 luminescence spectrometer (excitation, 314; emission, 418nm). 

Phrase: "Fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "read on a Perkin-Elmer LS-5 luminescence spectrometer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0034754:Read [Daily or Recreational Activity]
   742   C0183395:Spectrometer [Medical Device]
   742   C1450275:luminescence [Natural Phenomenon or Process]
   742   C1705179:read [Finding]
   742   C1710143:Spectrometer [Manufactured Object]

Phrase: "(excitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "314"

Phrase: "; emission,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0233929:Emission [Body Substance]
  1000   C2349995:Emission [Substance]

Phrase: "418nm"

Phrase: ")."
Processing 00000000.tx.49: Preparation and Analysis of Rat Testicular Enzyme Extract Testes were removed from male Sprague-Dawley rats (280g), and the tissues (7.3g) were homogenized using a Polytron kinematic homogenizer in an equal volume to weight of ice-cold 25mM Tris-buffered saline, pH 7.4.

Phrase: "Preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "Analysis of Rat Testicular Enzyme Extract Testes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "removed from male Sprague-Dawley rats"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   833   C0034715:Rats, Sprague-Dawley [Mammal]
   790   C2699239:Sprague-Dawley [Mammal]
   753   C0024554:Male [Finding]
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0086582:male [Population Group]
   753   C0849355:Removed [Qualitative Concept]
   753   C1706180:Male [Qualitative Concept]
   753   C1706428:Male [Qualitative Concept]
   753   C1706429:Male [Organism Attribute]
   719 E C1883720:Remove [Activity]
   719 E C3244314:remove [Functional Concept]

Phrase: "(280g"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "(7.3g"

Phrase: ")"

Phrase: "were"

Phrase: "homogenized"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Polytron kinematic homogenizer in an equal volume"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0181200:homogenizer [Medical Device]

Phrase: "to weight"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005910:weight [Organism Attribute]
  1000   C0043100:Weight [Quantitative Concept]
  1000   C1305866:weight [Diagnostic Procedure]
  1000   C1705104:Weight [Idea or Concept]

Phrase: "of ice-cold 25mM Tris-buffered saline,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   810   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   799   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   799   C0036082:Saline [Substance]
   799   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   799   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.4."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.50: The homogenate was centrifuged for 5min at 1,000 g in a microcentrifuge at 4C. 

Phrase: "The homogenate"

Phrase: "was"

Phrase: "centrifuged for 5min at 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0179834:centrifuge [Medical Device]

Phrase: "000 g in a microcentrifuge"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439267:g% [Quantitative Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.51: The supernatant (equivalent of 0.1l) was assayed for EP24.15 activity using the QFS assay, and 250l (diluted up to 400l with 25mM Srensen buffer, pH 7.0(Na2PO4NaH2PO4) (20)) was fractionated by size exclusion chromatography as described for the inhibitor binding studies. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "(equivalent of 0.1l"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205163:Equivalent [Qualitative Concept]
   770   C0439185:equivalent [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "assayed for EP24.15 activity"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   838   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   784   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   762   C1150171:endopeptidase activity [Molecular Function]
   742   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]
   708   C0005507:Assay [Laboratory Procedure]
   708   C0243073:assay [Qualitative Concept]
   708   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the QFS assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "250l"

Phrase: "("

Phrase: "diluted up to 400l"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]

Phrase: "with 25mM Srensen buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "pH 7.0"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "(Na2PO4NaH2PO4"

Phrase: ")"

Phrase: "(20"

Phrase: ")"

Phrase: ")"

Phrase: "was"

Phrase: "fractionated by size exclusion chromatography"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
   862   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0456389:size [Spatial Concept]
   760   C0680251:EXCLUSION [Functional Concept]
   760   C1979893:Fractionated [Qualitative Concept]
   760   C2828389:Exclusion [Activity]

Phrase: "as"

Phrase: "described for the inhibitor binding studies."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0243122:binding [Functional Concept]
   753   C0947630:studies [Laboratory Procedure]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1552738:described [Idea or Concept]
   753   C1999216:Inhibitor [Qualitative Concept]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]
Processing 00000000.tx.52: 50l of each fraction was assayed for EP24.15 activity using the QFS activity. 

Phrase: "50l of each fraction"

Phrase: "was"

Phrase: "assayed for EP24.15 activity"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   838   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   784   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   762   C1150171:endopeptidase activity [Molecular Function]
   742   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]
   708   C0005507:Assay [Laboratory Procedure]
   708   C0243073:assay [Qualitative Concept]
   708   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the QFS activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.53: HPLC Recombinant EP24.15 (100g in 100l) was reduced by incubation with 2-mercaptoethanol (2l) for 1h at 37C. 

Phrase: "HPLC Recombinant EP24.15"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   890   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   869   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   822   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0008562:HPLC [Laboratory Procedure]
   793   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   793   C1514798:recombinant [Organism]

Phrase: "(100g in 100l"

Phrase: ")"

Phrase: "was"

Phrase: "reduced by incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "with 2-mercaptoethanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025402:2-Mercaptoethanol [Organic Chemical]
           Mercaptoethanol

Phrase: "(2l"

Phrase: ")"

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.54: Alkylation of EP24.15 (100g in 100l) was achieved by a 1-h incubation at room temperature with 4-vinylpyridine (2l). 

Phrase: "Alkylation of EP24.15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0002074:Alkylation [Natural Phenomenon or Process]

Phrase: "(100g in 100l"

Phrase: ")"

Phrase: "was"

Phrase: "achieved by a 1-h incubation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0700308:h 1 [Element, Ion, or Isotope]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "with 4-vinylpyridine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0048740:4-vinylpyridine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0303984:Vinyl pyridine [Organic Chemical]

Phrase: "(2l"

Phrase: ")."
Processing 00000000.tx.55: Size exclusion chromatography was performed using a Waters HPLC system, comprising two 510pumps, a model 680gradient controller, a U6K injector, and a model 441UV absorbance detector. 

Phrase: "Size exclusion chromatography"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
  1000   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   827   C0008550:Chromatography [Laboratory Procedure]
   827   C0456389:size [Spatial Concept]
   827   C0680251:EXCLUSION [Functional Concept]
   827   C2828389:Exclusion [Activity]
   727 E C0302647:chromatograph [Medical Device]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Waters HPLC system,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   913   C1532950:Waters' system [Medical Device]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "comprising"

Phrase: "two 510pumps,"

Phrase: "a model 680gradient controller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0180112:Controller [Medical Device]

Phrase: "a U6K injector,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0181342:Injector [Medical Device]

Phrase: "and"

Phrase: "a model 441UV absorbance detector."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0180392:Detector [Medical Device]
   812   C1705235:Detector [Manufactured Object]
Processing 00000000.tx.56: The size exclusion column (TSK-GEL SW3000, Toya Soda Co., Japan) was eluted with 100mM ammonium acetate, pH 7.0,isocratically at a flow rate of 0.5 ml/min. 

Phrase: "The size exclusion column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: "(TSK-GEL SW3000,"

Phrase: "Toya Soda Co.,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: "was"

Phrase: "eluted with 100mM ammonium acetate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0051704:ammonium acetate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   760   C0002611:Ammonium [Inorganic Chemical]

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "isocratically at a flow rate of 0.5 ml/min."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0439445:mL/min [Quantitative Concept]
   760   C0444499:0/5 [Quantitative Concept]
   760   C2826285:Flow Rate [Quantitative Concept]
   739   C0439526:/mL [Quantitative Concept]
   739   C0702093:/min [Temporal Concept]
   739   C0806140:Flow [Natural Phenomenon or Process]
   739   C0871208:Rate [Activity]
   739   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.57: Absorbance of the emerging peaks was measured at 214nm. 

Phrase: "Absorbance of the emerging peaks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1268822:Absorbance [Clinical Attribute]
   760   C2825050:Absorbance [Phenomenon or Process]

Phrase: "was"

Phrase: "measured at 214nm."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.58: The column was calibrated with thyroglobulin, myosin, human -globulin, bovine serum albumin, and L-tyrosine. 

Phrase: "The column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "was"

Phrase: "calibrated with thyroglobulin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0040123:Thyroglobulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1527123:Thyroglobulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   734 E C3642448:Proloid [Pharmacologic Substance]

Phrase: "myosin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "human -globulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017649:Globulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bovine serum albumin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   901   C0728877:serum albumin [Laboratory or Test Result]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007452:Bovine [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "L-tyrosine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041485:L-Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Tyrosine
Processing 00000000.tx.59: Inhibitor Binding Studies and HPLC Analysis Recombinant EP24.15 (20g) was incubated with 125I-labeled cFP (1ng, 2.5106 cpm) and cold iodinated cFP (2g) prepared by the IODO-GEN method (21) in 200l of 25mM Srensen buffer, pH 7.0,in the presence or absence of 1mM dithiothreitol, for 15min at room temperature. 

Phrase: "Inhibitor Binding Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "HPLC Analysis Recombinant EP24.15"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   875   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   858   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   817   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   807   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0002778:Analysis [Laboratory Procedure]
   791   C0008562:HPLC [Laboratory Procedure]
   791   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   791   C0936012:Analysis [Research Activity]
   791   C1514798:recombinant [Organism]
   791   C1524024:analysis [Functional Concept]

Phrase: "(20g"

Phrase: ")"

Phrase: "was"

Phrase: "incubated with 125I-labeled cFP (1ng,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0055162:CFP [Therapeutic or Preventive Procedure]
   753   C1418482:CFP [Gene or Genome]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1708632:Labeled [Qualitative Concept]
   719 E C0181496:Label [Manufactured Object]
   719 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "2.5106 cpm)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0653998:2-CPM [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "cold iodinated cFP (2g"

Phrase: ")"

Phrase: "prepared by the IODO-GEN method"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0283030:Iodo-Gen [Organic Chemical,Pharmacologic Substance]
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]
   753   C1704351:GEN [Quantitative Concept]
   753   C2239486:Gen [Gene or Genome]
   719   C1521827:Prepare [Functional Concept]

Phrase: "(21"

Phrase: ")"

Phrase: "in 200l"

Phrase: "of 25mM Srensen buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of 1mM dithiothreitol,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "for 15min"

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.60: The mixture was then fractionated by size exclusion chromatography as described above, except the TSK-GEL SW3000 column was eluted with 25mM Srensen buffer, pH 7.0,at a flow rate of 0.5ml/min. 

Phrase: "The mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "fractionated by size exclusion chromatography"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
   862   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0456389:size [Spatial Concept]
   760   C0680251:EXCLUSION [Functional Concept]
   760   C1979893:Fractionated [Qualitative Concept]
   760   C2828389:Exclusion [Activity]

Phrase: "as described above,"

Phrase: "except the TSK-GEL SW3000 column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1185738:Column [Body Part, Organ, or Organ Component]
   812   C1706132:Column [Idea or Concept]

Phrase: "was"

Phrase: "eluted with 25mM Srensen buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "at a flow rate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2826285:Flow Rate [Quantitative Concept]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "of 0.5ml/min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]
Processing 00000000.tx.61: Fractions were collected at 0.5-min intervals and counted on a counter (RIASTAR, Packard Instrument Co., Canberra, Australia). 

Phrase: "Fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected at 0.5-min intervals"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0444499:0/5 [Quantitative Concept]
   753   C0702093:/min [Temporal Concept]
   753   C1272706:intervals [Temporal Concept]
   753   C1516695:Collected [Idea or Concept]
   753   C1516698:Collected [Functional Concept]
   719 E C1552654:Interval [Idea or Concept]
   719 E C1552713:Interval [Intellectual Product]

Phrase: "and"

Phrase: "counted on a counter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0677601:Counter [Manufactured Object]
   770   C1705206:Counter [Medical Device]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]

Phrase: "(RIASTAR,"

Phrase: "Packard Instrument Co.,"

Phrase: "Canberra,"

Phrase: "Australia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]

Phrase: ")."
Processing 00000000.tx.62: The column was calibrated prior to use as described previously. 

Phrase: "The column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "was"

Phrase: "calibrated prior to use"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0332152:Prior to [Temporal Concept]
           Prior
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]
   770   C2826257:PRIOR [Event]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously."
Processing 00000000.tx.63: Generation of EP24.15 Cysteine Mutants Double-stranded site-directed mutagenesis of rat EP24.15 was performed on a pGEX-2 (Pharmacia Biotech Inc.) derived EP24.15 expression vector pG-24.15 (22) modified for rapid screening of mutations by the addition of a unique restriction endonuclease site (EcoRI) that replaces the ApaI restriction site on the plasmodia. 

Phrase: "Generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "of EP24.15 Cysteine Mutants Double-stranded site-directed mutagenesis"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   809   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   786   C0079866:Mutagenesis [Molecular Function]
   786   C0205145:Site [Spatial Concept]
   786   C1515974:Site [Body Location or Region]
   786   C2825164:Site [Spatial Concept]
   786   C3146302:Mutagenesis [Laboratory Procedure]
   753   C0439851:Direct [Qualitative Concept]
   753   C1947931:Direct [Qualitative Concept]
   715 E C0439755:Directions [Spatial Concept]
   715 E C0449738:Direction [Spatial Concept]

Phrase: "of rat EP24.15"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   829   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   795   C0034693:Rat, NOS [Mammal]
   795   C0034721:Rat [Mammal]

Phrase: "was"

Phrase: "performed on a pGEX-2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Pharmacia Biotech Inc.) derived EP24.15 expression vector pG-24.15"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   830   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   824   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   794   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   794   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   785   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   785   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   785   C0185117:Expression [Therapeutic or Preventive Procedure]
   785   C0331955:Pharmacia [Health Care Related Organization]
   785   C0442335:Vector [Spatial Concept]
   785   C1266240:PG [Laboratory Procedure]
   785   C1441547:Derived [Qualitative Concept]
   785   C1705099:Vector [Idea or Concept]
   785   C3245521:derived [Idea or Concept]

Phrase: "(22"

Phrase: ")"

Phrase: "modified for rapid screening of mutations"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0026882:Mutations [Genetic Function]
   753   C0220908:Screening [Health Care Activity]
   753   C0220909:screening [Functional Concept]
   753   C0392747:Modified [Functional Concept]
   753   C0439831:Rapid [Qualitative Concept]
   753   C1698960:screening [Intellectual Product]
   753   C1710031:Screening [Diagnostic Procedure]
   753   C1710477:SCREENING [Research Activity]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "by the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of a unique restriction endonuclease site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1882940:Restriction Site [Nucleotide Sequence]
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "(EcoRI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "that"

Phrase: "replaces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550539:replaces [Idea or Concept]
  1000   C1553396:replaces [Idea or Concept]
  1000   C1554078:Replace [Idea or Concept]

Phrase: "the ApaI restriction site on the plasmodia."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1882940:Restriction Site [Nucleotide Sequence]
   748   C0205145:Site [Spatial Concept]
   748   C0443288:Restriction [Functional Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]
Processing 00000000.tx.64: Oligonucleotide primers were synthesized with mismatches coding for an amino acid change of Cys to Ser for each of the 14Cys residues present in the protein. 

Phrase: "Oligonucleotide primers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206415:Oligonucleotide Primers [Nucleic Acid, Nucleoside, or Nucleotide]
           Primer

Phrase: "were"

Phrase: "synthesized with mismatches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1883254:Synthesized [Activity]
   756   C1881865:Mismatch [Qualitative Concept]

Phrase: "coding for an amino acid change of Cys"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   800   C1953353:Amino acid change [Finding]
   770   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C2917660:Amino Acid [Pharmacologic Substance]
   744   C0001128:Acid [Chemical]
   744   C0009219:Coding [Occupational Activity]
   744   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C1705241:Change [Quantitative Concept]
   711 E C0805701:Code [Intellectual Product]

Phrase: "to Ser"

Phrase: "for each"

Phrase: "of the 14Cys residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "present in the protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
Processing 00000000.tx.65: Oligonucleotides were 5-phosphorylated with T4 polynucleotide kinase (New England Biolabs Inc., Beverley, MA) and annealed to the double-stranded expression vector plasmid. 

Phrase: "Oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "5-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "phosphorylated with T4 polynucleotide kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0032545:Polynucleotide Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1418707:POLYNUCLEOTIDE KINASE [Gene or Genome]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0032550:Polynucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(New England Biolabs Inc.,"

Phrase: "Beverley,"

Phrase: "MA)"

Phrase: "and"

Phrase: "annealed to the double-stranded expression vector plasmid."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   767   C1514152:Plasmid Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205173:Double [Functional Concept]
   744   C0442335:Vector [Spatial Concept]
   744   C1705099:Vector [Idea or Concept]
   744   C1705764:Double [Activity]
   744   C1705765:Double [Qualitative Concept]
   735   C1979882:Double strand [Qualitative Concept]
Processing 00000000.tx.66: Primers were extended and ligated in a single reaction, and the resulting plasmid DNA was selected for the ApaI to EcoRI mutation by digestion with ApaI (to cleave the wild-type DNA). 

Phrase: "Primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "and"

Phrase: "ligated in a single reaction,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]

Phrase: "and"

Phrase: "the resulting plasmid DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "selected for the ApaI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0066198:APAI [Organic Chemical,Pharmacologic Substance]
   737   C1707391:Select [Activity]

Phrase: "to EcoRI mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "by digestion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0012238:Digestion [Organism Function]
  1000   C2349986:Digestion [Research Activity]
   944 E C0443277:Peptic [Functional Concept]

Phrase: "with ApaI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0066198:APAI [Organic Chemical,Pharmacologic Substance]

Phrase: "(to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cleave"

Phrase: "the wild-type DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0079247:type dna [Molecular Biology Research Technique]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: ")."
Processing 00000000.tx.67: Plasmid DNA containing the desired mutation was transformed into competent DH5 bacterial cells and plated overnight on ampicillin plates to yield single colonies. 

Phrase: "Plasmid DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the desired mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "transformed into competent DH5 bacterial cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   773   C0563199:Bacterial cell [Bacterium]
   753   C0007634:Cells [Cell]
   753   C0086035:Competent [Qualitative Concept]
   753   C0521009:Bacterial [Qualitative Concept]
   753   C1510411:Transformed [Pathologic Function]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "plated overnight on ampicillin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "yield"

Phrase: "single colonies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439158:colonies [Quantitative Concept]
   827 E C1947989:Colony [Cell]
Processing 00000000.tx.68: The plasmid DNA was purified (Mini-Prep, QIAGEN, Inc., Santa Clarita, CA) and cleaved with EcoRI to screen for mutations. 

Phrase: "The plasmid DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "(Mini-Prep,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418885:PREP [Gene or Genome]
   861   C1425030:PreP [Gene or Genome]
   861   C1521827:PREP [Functional Concept]

Phrase: "QIAGEN,"

Phrase: "Inc.,"

Phrase: "Santa Clarita,"

Phrase: "CA)"

Phrase: "and"

Phrase: "cleaved with EcoRI to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205242:Cleaved [Spatial Concept]
   770   C0333853:Cleaved [Cell]

Phrase: "screen for mutations."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0026882:Mutations [Genetic Function]
   790   C0220908:screen [Health Care Activity]
   790   C1305399:screen [Functional Concept]
   790   C1705053:Screen [Medical Device]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.69: Mutations were confirmed by double-stranded template dideoxy sequencing with Sequenase (U.S. Biochemical Corp.). 

Phrase: "Mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "confirmed by double-stranded template dideoxy sequencing"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   778   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   748   C0205173:Double [Functional Concept]
   748   C0728990:TEMPLATE [Medical Device]
   748   C0750484:Confirmed [Idea or Concept]
   748   C1514575:Template [Conceptual Entity]
   748   C1553778:Sequencing [Intellectual Product]
   748   C1561491:Sequencing [Functional Concept]
   748   C1705542:Template [Idea or Concept]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   743   C1979882:Double strand [Qualitative Concept]
   714 E C1456348:Confirm [Qualitative Concept]

Phrase: "with Sequenase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0142005:sequenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2257064:sequenase [Genetic Function]

Phrase: "(U.S. Biochemical Corp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0683758:Corp. [Organization]

Phrase: ")."
Processing 00000000.tx.70: The double and triple Cys mutations were prepared in an identical manner. 

Phrase: "The double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "and"

Phrase: "triple Cys mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "prepared in an identical manner."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205280:Identical [Qualitative Concept]
   726   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.71: Expression and purification of the mutant proteins for biochemical characterization were as described (22). 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "purification of the mutant proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0597301:protein purification [Laboratory Procedure]
   760   C0243114:purification [Functional Concept]
   760   C1998793:Purification [Functional Concept]

Phrase: "for biochemical characterization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880022:Characterization [Activity]

Phrase: "were"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.72: Purification to homogeneity was assessed by SDS-polyacrylamide gel electrophoresis, and protein was quantitated by Bradford assay using bovine serum albumin as a standard (Pierce) (23). 

Phrase: "Purification to homogeneity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243114:purification [Functional Concept]
   790   C1998793:Purification [Functional Concept]

Phrase: "was"

Phrase: "assessed by SDS-polyacrylamide gel electrophoresis,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1382104:Gel [Substance]
   753   C1516048:Assessed [Activity]

Phrase: "and"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "quantitated by Bradford assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "bovine serum albumin as a standard"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   790   C0728877:serum albumin [Laboratory or Test Result]
   783 E C0523465:Albumin - serum [Laboratory Procedure]
   753   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0007452:Bovine [Mammal]
   753   C0229671:Serum [Body Substance]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]

Phrase: "(Pierce"

Phrase: ")"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.73: Yields of expressed protein were similar for all of the mutations; 

Phrase: "Yields of expressed protein"

Phrase: "were"

Phrase: "similar for all of the mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.74: aliquots were stored at 80C for subsequent study. 

Phrase: "aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "stored at 80C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]

Phrase: "for subsequent study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.75: Dynamic Light Scattering To measure the polydispersity of wild-type and C246S/C248S/C253S mutant EP24.15, dynamic light scattering was performed at 23C on a DynaPro 801molecular sizing instrument (Protein Solutions, Charlottesville, VA). 

Phrase: "Dynamic Light Scattering To"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C1882368:Dynamic Light Scattering [Laboratory Procedure]
   861   C0596837:Light Scattering [Phenomenon or Process]
   812   C0023693:Light [Natural Phenomenon or Process]
   812   C0439742:Scattering [Spatial Concept]
   812   C0729333:Dynamic [Functional Concept]
   812   C1306462:Light [Functional Concept]
   812   C1881376:Light [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "the polydispersity of wild-type"

Phrase: "and"

Phrase: "C246S/C248S/C253S mutant EP24.15,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   863   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   850   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   813   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "dynamic light scattering"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1882368:Dynamic Light Scattering [Laboratory Procedure]
   901   C0596837:Light Scattering [Phenomenon or Process]
   827   C0023693:Light [Natural Phenomenon or Process]
   827   C0439742:Scattering [Spatial Concept]
   827   C0729333:Dynamic [Functional Concept]
   827   C1306462:Light [Functional Concept]
   827   C1881376:Light [Qualitative Concept]

Phrase: "was"

Phrase: "performed at 23C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "on a DynaPro 801molecular sizing instrument"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0348000:Instrument [Medical Device]

Phrase: "(Protein Solutions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0037633:Solutions [Substance]
   827 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "Charlottesville,"

Phrase: "VA)."
Processing 00000000.tx.76: A 1mg/ml solution of each enzyme in 25 mM Tris, pH 7.4,100mM NaCl, with and without 0.1mM DTT was equilibrated for 1h before repetitive measurements were taken over a period of 30-45 min. 

Phrase: "A 1mg/ml solution of each enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037633:Solution [Substance]
   748   C0525069:Solution [Biomedical or Dental Material]

Phrase: "in 25 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "100mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "with"

Phrase: "and without 0.1mM DTT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0012789:DTT [Carbohydrate,Pharmacologic Substance]
   760   C1515981:And [Idea or Concept]

Phrase: "was"

Phrase: "equilibrated for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1442450:1H [Temporal Concept]

Phrase: "before repetitive measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "taken over a period of 30-45 min."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   767   C0456693:/30 min [Temporal Concept]
   767   C1442458:30 min [Temporal Concept]
   744   C0439531:/period [Temporal Concept]
   744   C0702093:/min [Temporal Concept]
   744   C1883727:Taken [Conceptual Entity]
   744   C1948053:Period [Temporal Concept]
   711 E C1515187:Take [Health Care Activity]
Processing 00000000.tx.77: Analysis to determine particle radius distribution and molecular weight was performed using software supplied by the manufacturer. 

Phrase: "Analysis to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "determine"

Phrase: "particle radius distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0520511:distribution [Idea or Concept]
   827   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "molecular weight"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0026385:Molecular Weight [Quantitative Concept]
   861   C0005910:weight [Organism Attribute]
   861   C0043100:Weight [Quantitative Concept]
   861   C1305866:weight [Diagnostic Procedure]
   861   C1521991:Molecular [Qualitative Concept]
   861   C1705104:Weight [Idea or Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "supplied by the manufacturer."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0947322:Manufacturer [Intellectual Product]
   770   C1705426:Manufacturer [Population Group]
   770   C1999230:Supplied [Activity]
   737 E C0243163:supply [Idea or Concept]
   737 E C0699914:supply [Quantitative Concept]
   737 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   737 E C1561604:supply [Functional Concept]
   737 E C1875802:SUPPLY [Medical Device]
Processing 00000000.tx.78: Inhibitor Binding Assay 2 g of EP24.15 was incubated in a total volume of 200l of 1mM Srensen buffer, pH 7.4,with 10nM cFP, 20,000cpm of 125I-cFP in the absence or presence of 0.1mM DTT, at 37C for 30 min. 

Phrase: "Inhibitor Binding Assay 2 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439267:g% [Quantitative Concept]

Phrase: "of EP24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "was"

Phrase: "incubated in a total volume of 200l of 1mM Srensen buffer,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   756   C0449468:Total Volume [Quantitative Concept]
           *Volume
   738   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   738   C0439175:% total [Quantitative Concept]
   738   C0439810:Total [Qualitative Concept]
   738   C1439852:Incubated [Laboratory Procedure]
   738   C1690016:% volume [Qualitative Concept]
   738   C1705102:Volume [Intellectual Product]
   738   C2700258:Volume [Laboratory Procedure]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "with 10nM cFP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0055162:CFP [Therapeutic or Preventive Procedure]
   861   C1418482:CFP [Gene or Genome]

Phrase: "20,"

Phrase: "000cpm of 125I-cFP"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of 0.1mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "at 37C"

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.79: 1g of hydroxyapatite (Bio-Rad) was suspended in 6ml of 1mM Srensen buffer, pH 7.0,and allowed to settle. 

Phrase: "1g of hydroxyapatite"

Phrase: "(Bio-Rad)"

Phrase: "was"

Phrase: "suspended in 6ml of 1mM Srensen buffer,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C1553389:suspended [Idea or Concept]
   748   C1553403:suspended [Idea or Concept]
   748   C1705537:Suspended [Functional Concept]

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "allowed to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0683607:allowed [Social Behavior]

Phrase: "settle."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1266099:SETTLE [Neoplastic Process]
Processing 00000000.tx.80: The top layer was aspirated to remove free floating particles, and the volume made up to 6ml again; 

Phrase: "The top layer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0934502:Layer [Body Part, Organ, or Organ Component]
   861   C1522408:Layer [Qualitative Concept]
   861   C1561599:Layer [Intellectual Product]

Phrase: "was"

Phrase: "aspirated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0700198:Aspirated [Pathologic Function]
   966 E C0370199:Aspirate [Body Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "free floating particles,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597177:particles [Chemical Viewed Structurally]
   734   C0443223:Free-floating [Qualitative Concept]

Phrase: "and"

Phrase: "the volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0449468:*Volume [Quantitative Concept]
  1000   C1690016:% volume [Qualitative Concept]
  1000   C1705102:Volume [Intellectual Product]
  1000   C2700258:Volume [Laboratory Procedure]

Phrase: "made up to 6ml again"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1881534:Make [Functional Concept]

Phrase: ";"
Processing 00000000.tx.81: this process was repeated 3times. 

Phrase: "this process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "was"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "3times."
Processing 00000000.tx.82: 200 l of the hydroxyapatite suspension was added to the protein mixture and incubated on ice for 30min with regular vortexing. 

Phrase: "200 l of the hydroxyapatite suspension"

Phrase: "was"

Phrase: "added to the protein mixture"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439962:Mixture [Substance]
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "incubated on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 30min"

Phrase: "with regular vortexing."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0439648:vortexing [Spatial Concept]
   861   C0724378:vortexing [Organic Chemical,Pharmacologic Substance]
   827 E C2719416:Vortex [Pharmacologic Substance]
Processing 00000000.tx.83: The inhibitor enzyme-hydroxyapatite complex was precipitated by centrifugation at 7,500g for 5min, and the supernatant was removed. 

Phrase: "The inhibitor enzyme-hydroxyapatite complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "precipitated by centrifugation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "at 7,"

Phrase: "500g for 5min,"

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "removed."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]
Processing 00000000.tx.84: The pellet was washed 3times in 300l of 1mM Srensen buffer, pH 7.0, before being resuspended and counted along with the supernatant and the pooled wash fractions. 

Phrase: "The pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "3times in 300l of 1mM Srensen buffer,"

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "before"

Phrase: "being"

Phrase: "resuspended"

Phrase: "and"

Phrase: "counted along with the supernatant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1550101:Supernatant [Body Substance]
   726   C0750480:Count [Activity]
   726   C1705566:Count [Quantitative Concept]

Phrase: "and"

Phrase: "the pooled wash fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.85: The number of counts bound in the pellet fraction was taken as a percentage of the total counts. 

Phrase: "The number of counts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "bound in the pellet fraction"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0332297:bound [Spatial Concept]
   760   C0441436:Pellet [Manufactured Object]
   760   C0993610:Pellet [Biomedical or Dental Material]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   760   C1689898:% bound [Quantitative Concept]
   760   C1998480:Pellet [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "was"

Phrase: "taken as a percentage of the total counts."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   744   C0439157:counts [Quantitative Concept]
   744   C0439165:Percentage [Quantitative Concept]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C1549488:Percentage [Idea or Concept]
   744   C1561533:Percentage [Idea or Concept]
   744   C1883727:Taken [Conceptual Entity]
   711 E C0750480:Count [Activity]
   711 E C1515187:Take [Health Care Activity]
   711 E C1705566:Count [Quantitative Concept]
Processing 00000000.tx.86: RESULTS Both recombinant and tissue-derived EP24.15 exhibited a marked activation (approximately 8-fold) in the presence of 0.1mM DTT in comparison with the absence of reducing agent (Fig. 1). 

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "Both recombinant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514798:recombinant [Organism]

Phrase: "and"

Phrase: "tissue-derived EP24.15"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   890   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   869   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   822   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   793   C0040300:Tissue [Tissue]
   793   C1441547:Derived [Qualitative Concept]
   793   C1547928:Tissue [Intellectual Product]
   793   C3245521:derived [Idea or Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a marked activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "(approximately 8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 0.1mM DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "in comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "with the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of reducing agent"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0376446:reducing agent [Indicator, Reagent, or Diagnostic Aid]
   861   C0392756:Reducing [Qualitative Concept]
   861   C0450442:Agent [Chemical Viewed Functionally]
   861   C1254351:Agent [Pharmacologic Substance]
   861   C1521826:Agent [Intellectual Product]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.87: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.88: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.89: Activation of recombinant and native EP24.15 by DTT. 

Phrase: "Activation of recombinant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "native EP24.15 by DTT."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   838   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   784   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0012789:DTT [Carbohydrate,Pharmacologic Substance]
   742   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   742   C0302891:Native [Functional Concept]
Processing 00000000.tx.90: Recombinant enzyme (n=3S.E.) and rat testes extract (mean of duplicate samples) were incubated for 30min at 37C with 0.1g of QFS substrate in 2.5ml of Tris-buffered saline in the presence and absence of 0.1mM DTT. 

Phrase: "Recombinant enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "(n=3S.E.)"

Phrase: "and"

Phrase: "rat testes"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   983   C1882878:Rat Testis [Body Part, Organ, or Organ Component]
   861   C0021358:Testes [Body Part, Organ, or Organ Component]
   861   C0039597:Testes [Body Part, Organ, or Organ Component]
   827 E C0228018:teste [Body Part, Organ, or Organ Component]
   827 E C1278981:Testis [Body Part, Organ, or Organ Component]
   761 E C0205070:Testicular [Spatial Concept]
   745 E C1284096:Testicle [Body Part, Organ, or Organ Component]

Phrase: "extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "(mean of duplicate samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C2348143:Sample Mean [Quantitative Concept]
           Mean
   770   C0444504:Mean [Quantitative Concept]
   770   C2347634:Mean [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "incubated for 30min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C"

Phrase: "with 0.1g"

Phrase: "of QFS substrate"

Phrase: "in 2.5ml"

Phrase: "of Tris-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "absence of 0.1mM DTT."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.91: Results are expressed as fold activation, relative to activity in the absence of DTT. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as fold activation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332462:Fold [Spatial Concept]
   770   C1879547:Activation [Activity]
   770   C1880834:FOLD [Phenomenon or Process]

Phrase: "relative to activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of DTT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:DTT [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.92: [View Larger Version of this Image (18K GIF file)] Under non-reducing conditions, fractionation of recombinant endopeptidase 24.15by size exclusion chromatography revealed aggregates of approximately 150,240,and >300 kDa in addition to the monomeric species of 75kDa (Fig. 2A). 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(18K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "]"

Phrase: "Under non-reducing conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "fractionation of recombinant endopeptidase 24.15by size exclusion chromatography revealed aggregates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0016640:fractionation [Laboratory Procedure]
   738   C0524811:fractionation [Therapeutic or Preventive Procedure]
   738   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "of approximately 150,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332232:Approximately [Qualitative Concept]

Phrase: "240,"

Phrase: "and >"

Phrase: "300 kDa in addition to the monomeric species of 75kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1532717:kDa [Quantitative Concept]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.93: However, once subjected to reduction or reduction and alkylation, these aggregates dissociated, and EP24.15 eluted as a single species of 75kDa (Fig. 2, C and D). 

Phrase: "However,"

Phrase: "once"

Phrase: "subjected to reduction"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0301630:Reduction [Natural Phenomenon or Process]
   790   C0392756:Reduction [Qualitative Concept]
   790   C0441610:Reduction [Therapeutic or Preventive Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "or"

Phrase: "reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "alkylation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002074:Alkylation [Natural Phenomenon or Process]

Phrase: "these aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "dissociated"

Phrase: ","

Phrase: "and"

Phrase: "EP24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "eluted as a single species of 75kDa"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   748   C1705920:Species [Conceptual Entity]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.94: If simply reduced prior to fractionation by size exclusion chromatography under non-reducing conditions, EP24.15 eluted in both the monomeric and an approximately 150-kDa aggregated form (Fig. 2B) suggesting a rapid and dynamic formation of multimeric forms. 

Phrase: "If"

Phrase: "simply"

Phrase: "reduced prior to fractionation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0332152:Prior to [Temporal Concept]
           Prior
   770   C0016640:fractionation [Laboratory Procedure]
   770   C0392756:Reduced [Qualitative Concept]
   770   C0524811:fractionation [Therapeutic or Preventive Procedure]
   770   C2826257:PRIOR [Event]
   770   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "by size exclusion chromatography"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
  1000   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   827   C0008550:Chromatography [Laboratory Procedure]
   827   C0456389:size [Spatial Concept]
   827   C0680251:EXCLUSION [Functional Concept]
   827   C2828389:Exclusion [Activity]
   727 E C0302647:chromatograph [Medical Device]

Phrase: "under non-reducing conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "EP24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "eluted in both"

Phrase: "the monomeric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "an approximately 150-kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532717:kDa [Quantitative Concept]

Phrase: "aggregated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332621:Aggregated [Functional Concept]
   966 E C0205418:Aggregate [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "dynamic formation of multimeric forms."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
Processing 00000000.tx.95: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.96: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.97: Size exclusion chromatography analysis of recombinant EP24.15. 

Phrase: "Size exclusion chromatography analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
   756   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
   756   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]

Phrase: "of recombinant EP24.15."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   911   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   829   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   795   C1514798:recombinant [Organism]
Processing 00000000.tx.98: Recombinant EP24.15 was reduced using -mercaptoethanol and/or alkylated with 4-vinylpyridine prior to fractionation on a TSK-GEL column at a flow rate of 0.5ml/min. 

Phrase: "Recombinant EP24.15"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   911   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   829   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   795   C1514798:recombinant [Organism]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "using -"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mercaptoethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "and/or"

Phrase: "alkylated with 4-vinylpyridine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0303984:Vinyl pyridine [Organic Chemical]

Phrase: "prior to fractionation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016640:fractionation [Laboratory Procedure]
  1000   C0524811:fractionation [Therapeutic or Preventive Procedure]
  1000   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "on a TSK-GEL column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: "at a flow rate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2826285:Flow Rate [Quantitative Concept]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "of 0.5ml/min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]
Processing 00000000.tx.99: The absorbance of the emerging peaks was measured at 214nm. 

Phrase: "The absorbance of the emerging peaks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1268822:Absorbance [Clinical Attribute]
   753   C2825050:Absorbance [Phenomenon or Process]

Phrase: "was"

Phrase: "measured at 214nm."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.100: A, recEP24.15; 

Phrase: "A,"

Phrase: "recEP24.15"

Phrase: ";"
Processing 00000000.tx.101: B, reduced recEP24.15; 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "reduced recEP24.15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0392756:Reduced [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.102: C, alkylated recEP24.15; 

Phrase: "C,"

Phrase: "alkylated recEP24.15"

Phrase: ";"
Processing 00000000.tx.103: and D, reduced and alkylated recEP24.15. 

Phrase: "and"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "and"

Phrase: "alkylated recEP24.15."
Processing 00000000.tx.104: Peaks 1, 2, 3, and 4correspond to molecular masses of approximately >300, 240,150,and 75kDa, respectively. 

Phrase: "Peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:Peak [Quantitative Concept]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4correspond to molecular masses of approximately"

Phrase: ">300,"

Phrase: "240,"

Phrase: "150,"

Phrase: "and"

Phrase: "75kDa,"

Phrase: "respectively."
Processing 00000000.tx.105: [View Larger Version of this Image (18K GIF file)] Analysis of rat testicular soluble extract indicates that the formation of EP24.15 multimeric species is not simply a function of the recombinant protein in a highly purified and concentrated form. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(18K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] Analysis of rat testicular soluble extract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "indicates"

Phrase: "that"

Phrase: "the formation of EP24.15 multimeric species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0220781:formation [Biologic Function]
   738   C0439634:formation [Spatial Concept]
   738   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "not simply"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "a function of the recombinant protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0815043:function protein [Amino Acid, Peptide, or Protein]
   783   C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "in a highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "and"

Phrase: "concentrated form."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]
Processing 00000000.tx.106: Size exclusion chromatography of the rat testes extract under non-reducing conditions showed that the vast majority of EP24.15 (determined following thiol activation of collected fractions) corresponded to a molecular mass much greater than 75kDa (Fig. 3). 

Phrase: "Size exclusion chromatography of the rat testes"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
   814   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   761   C0426327:Size of testicle [Clinical Attribute]
           Testicle size
   748   C0008550:Chromatography [Laboratory Procedure]
   748   C0456389:size [Spatial Concept]
   748   C0680251:EXCLUSION [Functional Concept]
   748   C2828389:Exclusion [Activity]

Phrase: "extract under non-reducing conditions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0392756:Reducing [Qualitative Concept]
   760   C1518422:Non [Functional Concept]
   760   C2828366:Extract [Substance]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the vast majority of EP24.15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0680220:majority [Social Behavior]

Phrase: "("

Phrase: "determined"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "thiol activation of collected fractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: ")"

Phrase: "corresponded to a molecular mass"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   760   C0577559:Mass [Finding]
   760   C1306372:*Mass [Quantitative Concept]
   760   C1521991:Molecular [Qualitative Concept]

Phrase: "much greater than 75kDa"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0439093:Greater Than [Quantitative Concept]
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.107: However, when chromatographed under reducing conditions, the activity eluted as a single peak corresponding to the monomeric molecular mass of 75kDa. 

Phrase: "However,"

Phrase: "when"

Phrase: "chromatographed under reducing conditions,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0392756:Reducing [Qualitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0302647:chromatograph [Medical Device]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "the activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "eluted as a single peak"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C0444505:Peak [Quantitative Concept]

Phrase: "corresponding to the monomeric molecular mass of 75kDa."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   744   C0577559:Mass [Finding]
   744   C1306372:*Mass [Quantitative Concept]
   744   C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.108: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.109: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.110: Rat testes EP24.15 activity chromatographed under reducing and non-reducing conditions. 

Phrase: "Rat testes EP24.15 activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   866   C1150171:endopeptidase activity [Molecular Function]
   791   C0205177:Activity [Functional Concept]
   791   C0439167:% activity [Quantitative Concept]
   791   C0441655:Activity [Activity]
   791   C1561536:*Activity [Idea or Concept]
   708   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "chromatographed under reducing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0392756:Reducing [Qualitative Concept]
   756   C0302647:chromatograph [Medical Device]

Phrase: "and"

Phrase: "non-reducing conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.111: EP24.15 activity in rat testes was assayed (QFS) in the presence of 0.1mM DTT following fractionation (0.25ml) by size exclusion chromatography. 

Phrase: "EP24.15 activity in rat testes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C1150171:endopeptidase activity [Molecular Function]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "(QFS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 0.1mM DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "fractionation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016640:fractionation [Laboratory Procedure]
  1000   C0524811:fractionation [Therapeutic or Preventive Procedure]
  1000   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "(0.25ml"

Phrase: ")"

Phrase: "by size exclusion chromatography."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
  1000   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   827   C0008550:Chromatography [Laboratory Procedure]
   827   C0456389:size [Spatial Concept]
   827   C0680251:EXCLUSION [Functional Concept]
   827   C2828389:Exclusion [Activity]
   727 E C0302647:chromatograph [Medical Device]
Processing 00000000.tx.112: [View Larger Version of this Image (19K GIF file)] To determine whether the thiol activation of EP24.15 is a function of the protein's ability to bind substrate when either in the monomeric or multimeric forms, recombinant EP24.15 was incubated with the radiolabeled EP24.15-specific inhibitor cFP both in the presence and absence of a thiol-reducing agent. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(19K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the thiol activation of EP24.15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "a function of the protein's ability to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0815043:function protein [Amino Acid, Peptide, or Protein]
   774   C1527118:Protein Function [Molecular Function]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]
   738   C0001288:functional ability [Daily or Recreational Activity]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "when"

Phrase: "either in the monomeric"

Phrase: "or"

Phrase: "multimeric forms,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "recombinant EP24.15"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   911   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   829   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   795   C1514798:recombinant [Organism]

Phrase: "was"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "with the radiolabeled EP24.15-specific inhibitor cFP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0055162:CFP [Therapeutic or Preventive Procedure]
   790   C1418482:CFP [Gene or Genome]

Phrase: "both in the presence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0238767:Both [Spatial Concept]
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "absence of a thiol-reducing agent."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.113: Fractionation by size exclusion chromatography under either non-reducing (Fig. 4A) or reducing (Fig. 4B) conditions showed that the inhibitor binds almost exclusively to the monomeric form with approximately a 5-fold increase in the amount of the radiolabeled cFP bound to EP24.15 in the presence of DTT. 

Phrase: "Fractionation by size exclusion chromatography"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0016640:fractionation [Laboratory Procedure]
   760   C0524811:fractionation [Therapeutic or Preventive Procedure]
   760   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "under either non-reducing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392756:Reducing [Qualitative Concept]
   827   C1518422:Non [Functional Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: "or"

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: "conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "almost exclusively to the monomeric form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "with approximately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332232:Approximately [Qualitative Concept]

Phrase: "a 5-fold increase in the amount of the radiolabeled cFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0442805:Increase [Functional Concept]

Phrase: "bound to EP24.15"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   855   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0332297:bound [Spatial Concept]
   744   C1145667:Bound [Activity]
   744   C1167622:Bound [Molecular Function]
   744   C1689898:% bound [Quantitative Concept]
   744   C2349209:Bound [Conceptual Entity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of DTT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:DTT [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.114: The increase in the amount of cFP bound under reducing conditions is consistent with increased amounts of monomer; 

Phrase: "The increase in the amount of cFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "bound under reducing conditions"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0332297:bound [Spatial Concept]
   770   C0392756:Reducing [Qualitative Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "is"

Phrase: "consistent with increased amounts of monomer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: ";"
Processing 00000000.tx.115: hence thiol activation of EP24.15 likely reflects the conversion of an inactive multimer to an active monomer. 

Phrase: "hence thiol activation of EP24.15 likely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1879547:Activation [Activity]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the conversion of an inactive multimer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439836:Conversion [Functional Concept]

Phrase: "to an active monomer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596973:Monomer [Chemical Viewed Structurally]
Processing 00000000.tx.116: The change in the degree of EP24.15 aggregation (reduced versus non-reduced) is also reflected in the UV trace of protein absorbance (214nm). 

Phrase: "The change in the degree"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0025320:The change [Physiologic Function]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "of EP24.15 aggregation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   795   C0332621:Aggregation [Functional Concept]
   795   C0439168:% aggregation [Quantitative Concept]
   744   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   724 E C0205418:Aggregate [Qualitative Concept]
   717   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "versus"

Phrase: "non-reduced"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Reduced [Qualitative Concept]
   861   C1518422:Non [Functional Concept]

Phrase: ")"

Phrase: "is"

Phrase: "also"

Phrase: "reflected in the UV trace of protein absorbance"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0041625:UV [Natural Phenomenon or Process]
   744   C0442822:Trace [Quantitative Concept]
   744   C0558058:reflected [Mental Process]
   744   C1268822:Absorbance [Clinical Attribute]
   744   C1524031:Trace [Qualitative Concept]
   744   C1883002:Trace [Functional Concept]
   744   C1961129:uV [Quantitative Concept]
   744   C2825050:Absorbance [Phenomenon or Process]

Phrase: "(214nm"

Phrase: ")."
Processing 00000000.tx.117: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.118: 4. 

Phrase: "4."
Processing 00000000.tx.119: Effect of 1mM DTT on cFP binding to recEP24.15; 

Phrase: "Effect of 1mM DTT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on cFP binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "to recEP24.15"

Phrase: ";"
Processing 00000000.tx.120: analysis by size exclusion chromatography. 

Phrase: "analysis by size exclusion chromatography."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.121: Recombinant EP24.15 (20 g) was incubated with 125I-labeled cFP for 15min at room temperature and fractionated (0.25-ml fractions) under both non-reducing (A) and reducing conditions (B). 

Phrase: "Recombinant EP24.15"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   911   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   829   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   795   C1514798:recombinant [Organism]

Phrase: "(20 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "incubated with 125I-labeled cFP"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0055162:CFP [Therapeutic or Preventive Procedure]
   760   C1418482:CFP [Gene or Genome]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1708632:Labeled [Qualitative Concept]
   726 E C0181496:Label [Manufactured Object]
   726 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "for 15min"

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "fractionated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979893:Fractionated [Qualitative Concept]

Phrase: "(0.25-ml fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "under both non-reducing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Reducing [Qualitative Concept]
   861   C1518422:Non [Functional Concept]

Phrase: "(A)"

Phrase: "and"

Phrase: "reducing conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.122: The collected fractions were counted, and the number of counts/min bound to EP24.15 in fractions is shown in the solid bars. 

Phrase: "The collected fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "the number of counts/min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "bound to EP24.15"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   855   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0332297:bound [Spatial Concept]
   744   C1145667:Bound [Activity]
   744   C1167622:Bound [Molecular Function]
   744   C1689898:% bound [Quantitative Concept]
   744   C2349209:Bound [Conceptual Entity]

Phrase: "in fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "is"

Phrase: "shown in the solid bars."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205208:Solid [Qualitative Concept]
   760   C0302909:Solid [Substance]
   760   C1378566:Solid [Biomedical or Dental Material]
   760   C1707156:BARS [Gene or Genome]
   760   C3274014:BARS [Intellectual Product]
   760   C3541345:BARS [Intellectual Product]
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.123: The column effluent was monitored at 214nm, and the resulting UV trace (0.5absorbance unit at full scale) is shown above the bound cFP data. 

Phrase: "The column effluent"

Phrase: "was"

Phrase: "monitored at 214nm,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]

Phrase: "and"

Phrase: "the resulting UV trace"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0442822:Trace [Quantitative Concept]
   827   C1524031:Trace [Qualitative Concept]
   827   C1883002:Trace [Functional Concept]

Phrase: "(0.5absorbance unit at full scale"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439148:Unit [Quantitative Concept]
   753   C1519795:Unit [Quantitative Concept]
   753   C1704753:Unit [Manufactured Object]
   753   C1880519:Unit [Quantitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "shown above the bound cFP data."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0055162:CFP [Therapeutic or Preventive Procedure]
   753   C0332297:bound [Spatial Concept]
   753   C1145667:Bound [Activity]
   753   C1167622:Bound [Molecular Function]
   753   C1418482:CFP [Gene or Genome]
   753   C1511726:Data [Idea or Concept]
   753   C1689898:% bound [Quantitative Concept]
   753   C2349209:Bound [Conceptual Entity]
   753   C3245479:data [Medical Device]
   719   C1547282:Show [Intellectual Product]
Processing 00000000.tx.124: [View Larger Version of this Image (16K GIF file)] To determine which of the 14cysteine residues in EP24.15 amino acid sequence (Fig. 5) may be involved in the formation of the multimers and hence the regulation of endopeptidase activity, a series of mutant enzymes were generated. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(16K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "which of the 14cysteine residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "in EP24.15 amino acid sequence"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   827   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   807   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   807   C2917660:Amino Acid [Pharmacologic Substance]
   791   C0001128:Acid [Chemical]
   791   C0004793:Sequence [Nucleotide Sequence]
   791   C0162326:Sequence [Nucleotide Sequence]
   791   C0162327:Sequence [Nucleotide Sequence]
   791   C0202406:Acid [Laboratory Procedure]
   791   C1519249:Sequence [Functional Concept]
   720 E C1548958:Sequential [Idea or Concept]
   720 E C1705294:Sequential [Qualitative Concept]
   708   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "may"

Phrase: "be"

Phrase: "involved in the formation of the multimers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1314939:Involved [Functional Concept]
   748   C1522492:Formation [Functional Concept]
   748   C1979934:Multimers [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "hence"

Phrase: "the regulation of endopeptidase activity,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   926   C2262641:regulation of endopeptidase activity [Molecular Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "a series of mutant enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205549:Series [Quantitative Concept]
   760   C2348044:Series [Intellectual Product]

Phrase: "were"

Phrase: "generated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]
Processing 00000000.tx.125: The cysteine residues were converted systematically by site-directed mutagenesis to serine residues, and the activity and degree of thiol activation were analyzed using the QFS assay. 

Phrase: "The cysteine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "were"

Phrase: "converted"

Phrase: "systematically by site-directed mutagenesis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   760   C0079866:Mutagenesis [Molecular Function]
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
   760   C3146302:Mutagenesis [Laboratory Procedure]
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]

Phrase: "to serine residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "the activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "degree of thiol activation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the QFS assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.126: The mutant enzymes of cysteine residues 246,248,and 253showed high activity in the absence of DTT, up to 8-fold greater than observed for the wild-type and other mutated enzymes (Fig. 6A). 

Phrase: "The mutant enzymes of cysteine residues 246,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0014442:Enzymes [Enzyme,Organic Chemical]
   748   C0014445:enzymes [Functional Concept]

Phrase: "248,"

Phrase: "and"

Phrase: "253showed high activity in the absence of DTT,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "up to 8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "greater than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0439093:Greater Than [Quantitative Concept]
   833   C0443228:greater [Quantitative Concept]
   833   C1704243:Greater [Quantitative Concept]
   799 E C0549177:Great [Quantitative Concept]

Phrase: "observed for the wild-type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1441672:Observed [Functional Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "other mutated enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.127: When assayed in the presence of 0.1mM DTT, all three mutants showed only a modest activation in comparison with the substantial thiol activation observed for the wild-type and remaining mutant enzymes. 

Phrase: "When"

Phrase: "assayed in the presence of 0.1mM DTT,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0012789:DTT [Carbohydrate,Pharmacologic Substance]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   711   C0005507:Assay [Laboratory Procedure]
   711   C0243073:assay [Qualitative Concept]
   711   C1510438:Assay [Laboratory Procedure]

Phrase: "all three mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a modest activation in comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "with the substantial thiol activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "observed for the wild-type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1441672:Observed [Functional Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "remaining mutant enzymes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]
Processing 00000000.tx.128: Interestingly, cysteine residues 246and 253are unique to EP24.15 in contrast to EP24.16, which does not exhibit thiol activation, whereas cysteine residue 248is conserved. 

Phrase: "Interestingly,"

Phrase: "cysteine residues 246and 253are"

Phrase: "unique to EP24.15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1710548:Unique [Qualitative Concept]

Phrase: "in contrast to EP24.16,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0286406:endopeptidase 3.4.24.16 [Amino Acid, Peptide, or Protein,Enzyme]
           endopeptidase 24.16
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "which"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "thiol activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "whereas"

Phrase: "cysteine residue 248is"

Phrase: "conserved."
Processing 00000000.tx.129: Therefore, a double mutant (C246S/C253S) and a triple mutant (C246S/C248S/C253S) were generated in the same fashion. 

Phrase: "Therefore,"

Phrase: "a double mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(C246S/C253S"

Phrase: ")"

Phrase: "and"

Phrase: "a triple mutant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205174:Triple [Quantitative Concept]
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(C246S/C248S/C253S"

Phrase: ")"

Phrase: "were"

Phrase: "generated in the same fashion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0445247:Same [Qualitative Concept]
   760   C3146294:Generated [Activity]
Processing 00000000.tx.130: Activity assays demonstrated that both of these mutants have high intrinsic activity in the absence of a reductant and do not demonstrate enhanced activity in the presence of DTT (Fig. 6B). 

Phrase: "Activity assays"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "both of these mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0238767:Both [Spatial Concept]
   770   C0596988:mutants [Cell or Molecular Dysfunction]
   770   C1706086:Both [Qualitative Concept]

Phrase: "have"

Phrase: "high intrinsic activity in the absence of a reductant"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0205102:Intrinsic [Spatial Concept]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0439674:Intrinsic [Functional Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "demonstrate"

Phrase: "enhanced activity in the presence of DTT (Fig. 6B"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1707919:Enhanced Activity [Quantitative Concept]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.131: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.132: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.133: Amino acid sequence of EP24.15 (8). 

Phrase: "Amino acid sequence of EP24.15"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   782   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   760   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C2917660:Amino Acid [Pharmacologic Substance]
   739   C0001128:Acid [Chemical]
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C0202406:Acid [Laboratory Procedure]
   739   C1519249:Sequence [Functional Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.134: The 14cysteine residues are highlighted in bold type. 

Phrase: "The 14cysteine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "are"

Phrase: "highlighted in bold type."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332307:Type [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.135: The cysteine residues unique to EP24.15 upon sequence comparison with EP24.16 are underlined. 

Phrase: "The cysteine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "unique to EP24.15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1710548:Unique [Qualitative Concept]

Phrase: "upon sequence comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707455:Comparison [Activity]

Phrase: "with EP24.16"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0286406:endopeptidase 3.4.24.16 [Amino Acid, Peptide, or Protein,Enzyme]
           endopeptidase 24.16
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "are"

Phrase: "underlined."
Processing 00000000.tx.136: Cysteine residues 246,248,and 253,shown to be important for the thiol activation of EP24.15, are circled. 

Phrase: "Cysteine residues 246,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "248,"

Phrase: "and"

Phrase: "253,"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "important for the thiol activation"

Phrase: "of EP24.15,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "are"

Phrase: "circled."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1282913:Circle [Spatial Concept]
   966   C1551714:Circle [Population Group]
Processing 00000000.tx.137: The classical HEXXH motif, typical of zinc metalloproteases, is shown in bold type and is double underlined. 

Phrase: "The classical HEXXH motif,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "typical of zinc metalloproteases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3538928:Typical [Qualitative Concept]

Phrase: "is"

Phrase: "shown in bold type"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332307:Type [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "is"

Phrase: "double underlined."
Processing 00000000.tx.138: [View Larger Version of this Image (39K GIF file)] Fig. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(39K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.139: 6. 

Phrase: "6."
Processing 00000000.tx.140: Activation (QFS hydrolysis) of the wild-type and mutant enzymes by DTT. 

Phrase: "Activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "(QFS hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: ")"

Phrase: "of the wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutant enzymes by DTT."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0014442:Enzymes [Enzyme,Organic Chemical]
   770   C0014445:enzymes [Functional Concept]
Processing 00000000.tx.141: Recombinant wild-type (WT) and mutant EP24.15 (0.5g) were incubated with 0.1g of QFS at 37C for 30min in the presence or absence of 0.1mM DTT. 

Phrase: "Recombinant wild-type (WT)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1883559:Wild Type [Organism Attribute]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutant EP24.15"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   911   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   829   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   795   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(0.5g"

Phrase: ")"

Phrase: "were"

Phrase: "incubated with 0.1g of QFS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1710236:Substrate [Manufactured Object]

Phrase: "at 37C"

Phrase: "for 30min"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of 0.1mM DTT."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.142: A, single mutants versus wild type in the presence and absence of 0.1mM; 

Phrase: "A,"

Phrase: "single mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "versus"

Phrase: "wild type in the presence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "absence of 0.1mM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: ";"
Processing 00000000.tx.143: B, double and triple mutants versus wild type in the presence and absence of 0.1mM DTT. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "and"

Phrase: "triple mutants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205174:Triple [Quantitative Concept]
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "versus"

Phrase: "wild type in the presence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "absence of 0.1mM DTT."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.144: The data are representative of four separate experiments. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "representative of four separate experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.145: [View Larger Version of this Image (33K GIF file)] Wild-type and C246S/C248S/C253S mutant EP24.15 were subject to dynamic light-scattering analysis to ascertain their size distribution in solution in the presence and absence of DTT. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(33K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] Wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "C246S/C248S/C253S mutant EP24.15"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   863   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   850   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   813   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "were subject to dynamic light-scattering analysis to"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   800   C1882368:Dynamic Light Scattering [Laboratory Procedure]
   770   C0596837:Light Scattering [Phenomenon or Process]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0023693:Light [Natural Phenomenon or Process]
   744   C0439742:Scattering [Spatial Concept]
   744   C0681850:Subject [Group]
   744   C0729333:Dynamic [Functional Concept]
   744   C0936012:Analysis [Research Activity]
   744   C1306462:Light [Functional Concept]
   744   C1524024:analysis [Functional Concept]
   744   C1550501:{Subject} [Idea or Concept]
   744   C1706203:Subject [Idea or Concept]
   744   C1881376:Light [Qualitative Concept]
   744   C2349001:Subject [Human]
   744   C2697811:Subject [Functional Concept]

Phrase: "ascertain"

Phrase: "their size distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "in solution in the presence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0037633:Solution [Substance]
   760   C0150312:In [Quantitative Concept]
   760   C0332285:In [Spatial Concept]
   760   C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "absence of DTT."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]
Processing 00000000.tx.146: The wild-type enzyme exhibited polydispersity or aggregation in the absence of reductant, reflected by a wider distribution of radii. 

Phrase: "The wild-type enzyme"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "polydispersity"

Phrase: "or"

Phrase: "aggregation in the absence of reductant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]

Phrase: "reflected by a wider distribution of radii."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0520511:distribution [Idea or Concept]
   748   C0558058:reflected [Mental Process]
   748   C1704711:Distribution [Functional Concept]
   714   C0034627:Radius [Body Part, Organ, or Organ Component]
   714   C0332464:Wide [Spatial Concept]
   714   C1279083:Radius [Body Part, Organ, or Organ Component]
   714   C1306504:Radius [Quantitative Concept]
Processing 00000000.tx.147: In comparison the reduced form appears monomeric based on the radius size and the calculated molecular weight. 

Phrase: "In comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "the reduced form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "monomeric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "based on the radius size"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0034627:Radius [Body Part, Organ, or Organ Component]
   760   C0456389:size [Spatial Concept]
   760   C1279083:Radius [Body Part, Organ, or Organ Component]
   760   C1306504:Radius [Quantitative Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "the calculated molecular weight."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0026385:Molecular Weight [Quantitative Concept]
   827   C0005910:weight [Organism Attribute]
   827   C0043100:Weight [Quantitative Concept]
   827   C1305866:weight [Diagnostic Procedure]
   827   C1521991:Molecular [Qualitative Concept]
   827   C1705104:Weight [Idea or Concept]
   755 E C0567416:Molecule [Substance]
Processing 00000000.tx.148: When the C246S/C248S/C253S mutant was subjected to the same measurements both the reduced and non-reduced forms appeared monomeric (Table I). 

Phrase: "When"

Phrase: "the C246S/C248S/C253S mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "subjected to the same measurements"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0242485:measurements [Functional Concept]
   760   C0445247:Same [Qualitative Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "both the reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "and"

Phrase: "non-reduced forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0348078:forms [Qualitative Concept]
   827   C0376315:Forms [Manufactured Object]
   793 E C1522492:Form [Functional Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "monomeric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.149: Table I. 

Phrase: "Table I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.150: Dynamic light scattering of reduced and non-reduced EP24.15 Distribution of particle radii (S.D.) and estimated molecular mass were determined by dynamic light scattering for the wild-type (WT) and triple cysteine mutants (1.0mg/ml) in the presence and absence of 0.1mM DTT. 

Phrase: "Dynamic light scattering of reduced"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C1882368:Dynamic Light Scattering [Laboratory Procedure]
   806   C0596837:Light Scattering [Phenomenon or Process]
   760   C0023693:Light [Natural Phenomenon or Process]
   760   C0439742:Scattering [Spatial Concept]
   760   C0729333:Dynamic [Functional Concept]
   760   C1306462:Light [Functional Concept]
   760   C1881376:Light [Qualitative Concept]

Phrase: "and"

Phrase: "non-reduced EP24.15 Distribution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C0520511:distribution [Idea or Concept]
   791   C1704711:Distribution [Functional Concept]
   708   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "of particle radii"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034627:Radius [Body Part, Organ, or Organ Component]
   827   C1279083:Radius [Body Part, Organ, or Organ Component]
   827   C1306504:Radius [Quantitative Concept]

Phrase: "(S.D.)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "estimated molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]

Phrase: "were"

Phrase: "determined by dynamic light scattering"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C1882368:Dynamic Light Scattering [Laboratory Procedure]
   806   C0596837:Light Scattering [Phenomenon or Process]
   760   C0023693:Light [Natural Phenomenon or Process]
   760   C0439742:Scattering [Spatial Concept]
   760   C0729333:Dynamic [Functional Concept]
   760   C1306462:Light [Functional Concept]
   760   C1881376:Light [Qualitative Concept]

Phrase: "for the wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "triple cysteine mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "(1.0mg/ml) in the presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "absence of 0.1mM DTT."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.151: The estimated molecular mass of the various EP24.15 forms was calculated from the hydrodynamic radius of the particle. 

Phrase: "The estimated molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]

Phrase: "of the various EP24.15 forms"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   793   C0348078:forms [Qualitative Concept]
   793   C0376315:Forms [Manufactured Object]
   760 E C1522492:Form [Functional Concept]
   723   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   703   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "calculated from the hydrodynamic radius of the particle."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0034627:Radius [Body Part, Organ, or Organ Component]
   744   C0444686:Calculated [Functional Concept]
   744   C0597177:Particle [Chemical Viewed Structurally]
   744   C1279083:Radius [Body Part, Organ, or Organ Component]
   744   C1306504:Radius [Quantitative Concept]
   744   C1441506:Calculated [Activity]
   744   C1443182:Calculated [Laboratory Procedure]
   744   C2936194:Hydrodynamic [Natural Phenomenon or Process]
Processing 00000000.tx.152: Sample Molecular mass Radius kDa nmS.D. 

Phrase: "Sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "Molecular mass Radius kDa nmS.D."
Processing 00000000.tx.153: WTDTT 1423 12.8 7.6 WT+DTT 96 4.2 1.5 C246S/C248S/C253SDTT 90 4.1 1.2 C246S/C248S/C253S+DTT 79 3.9 0.9 To assess the catalytic site availabilty, both C246S/C253S and C246S/C248S/C253S EP24.15 mutant enzymes as well as the wild type were incubated with 125I-cFP in the presence and absence of 0.1mM DTT. 

Phrase: "WTDTT 1423 12.8 7.6 WT+DTT 96 4.2 1.5 C246S/C248S/C253SDTT 90 4.1 1.2 C246S/C248S/C253S+DTT 79 3.9 0.9 To"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   850   C0441731:Type 3 [Classification]
   802   C0457499:Type 5 [Intellectual Product]
   798   C0441729:Type 1 [Classification]
   795   C0441730:Type 2 [Classification]
   791   C0441732:Type 4 [Classification]
   785   C1883559:Wild Type [Organism Attribute]
   781   C0012789:DTT [Carbohydrate,Pharmacologic Substance]
   781   C0332307:Type [Qualitative Concept]
   781   C0439083:>90 [Quantitative Concept]
   781   C0439087:<90 [Quantitative Concept]
   781   C0445392:Wild [Intellectual Product]
   781   C1547052:*Type [Quantitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the catalytic site availabilty,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0205681:Catalytic Site [Functional Concept]
   734   C0600499:catalytic site [Amino Acid Sequence]

Phrase: "both C246S/C253S"

Phrase: "and"

Phrase: "C246S/C248S/C253S EP24.15 mutant enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   788   C0014442:Enzymes [Enzyme,Organic Chemical]
   788   C0014445:enzymes [Functional Concept]

Phrase: "as well as"

Phrase: "the wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "were"

Phrase: "incubated with 125I-cFP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0055162:CFP [Therapeutic or Preventive Procedure]
   770   C1418482:CFP [Gene or Genome]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "absence of 0.1mM DTT."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.154: The enzyme-inhibitor complex was precipitated using hydroxyapatite, and the bound cFP was compared with the free cFP. 

Phrase: "The enzyme-inhibitor complex"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   913   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0014432:Enzyme inhibitor [Pharmacologic Substance]
   901   C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]
   827   C1999216:Inhibitor [Qualitative Concept]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "precipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "hydroxyapatite,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0115137:Hydroxyapatite [Biomedical or Dental Material,Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "the bound cFP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0055162:CFP [Therapeutic or Preventive Procedure]
   861   C1418482:CFP [Gene or Genome]

Phrase: "was"

Phrase: "compared with the free cFP."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0055162:CFP [Therapeutic or Preventive Procedure]
   760   C0332296:free [Functional Concept]
   760   C1418482:CFP [Gene or Genome]
   760   C1707455:Compared [Activity]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
Processing 00000000.tx.155: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.156: 7, there was a 10-fold increase in the amount of inhibitor bound to the wild-type enzyme in the presence of DTT. 

Phrase: "7,"

Phrase: "there"

Phrase: "was"

Phrase: "a 10-fold increase in the amount of inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "bound to the wild-type enzyme"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0332297:bound [Spatial Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1145667:Bound [Activity]
   753   C1167622:Bound [Molecular Function]
   753   C1547052:*Type [Quantitative Concept]
   753   C1689898:% bound [Quantitative Concept]
   753   C2349209:Bound [Conceptual Entity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of DTT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:DTT [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.157: However, inhibitor binding to both mutant enzymes was the same in both reduced and non-reduced situations and similar to reduced wild-type EP24.15. 

Phrase: "However,"

Phrase: "inhibitor binding to both mutant enzymes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1149286:enzyme binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "the same in both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0445247:Same [Qualitative Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "and"

Phrase: "non-reduced situations"

Phrase: "and"

Phrase: "similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "to reduced wild-type EP24.15."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   875   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   858   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   842   C0441732:Type 4 [Classification]
   829   C0441731:Type 3 [Classification]
   817   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   807   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   807   C1883559:Wild Type [Organism Attribute]
   791   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   791   C0332307:Type [Qualitative Concept]
   791   C0392756:Reduced [Qualitative Concept]
   791   C0445392:Wild [Intellectual Product]
   791   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.158: This result indicates that the catalytic site of both the C246S/C253S and C246S/C248S/C253S mutants is available for binding regardless of the redox state of the environment. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "indicates"

Phrase: "that"

Phrase: "the catalytic site of both"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0205681:Catalytic Site [Functional Concept]
   806   C0600499:catalytic site [Amino Acid Sequence]
   806   C2945843:Site of [Qualitative Concept]
   760   C0007382:Catalytic [Natural Phenomenon or Process]
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "the C246S/C253S"

Phrase: "and"

Phrase: "C246S/C248S/C253S mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "available for binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: "regardless of the redox state"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0030012:redox state [Molecular Function]
           Redox
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "of the environment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014406:Environment [Spatial Concept]
Processing 00000000.tx.159: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.160: 7. 

Phrase: "7."
Processing 00000000.tx.161: Binding of cFP to recombinant EP24.15 in the presence and absence of DTT. 

Phrase: "Binding of cFP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "to recombinant EP24.15"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   911   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   829   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   795   C1514798:recombinant [Organism]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "absence of DTT."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]
Processing 00000000.tx.162: 2g of wild-type (WT) double and triple mutants were incubated with 125I-labeled cFP for 30min at 37C, and the enzyme-inhibitor complex was precipitated using hydroxyapatite. 

Phrase: "2g of wild-type"

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "and"

Phrase: "triple mutants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205174:Triple [Quantitative Concept]
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "incubated with 125I-labeled cFP"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0055162:CFP [Therapeutic or Preventive Procedure]
   760   C1418482:CFP [Gene or Genome]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1708632:Labeled [Qualitative Concept]
   726 E C0181496:Label [Manufactured Object]
   726 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "for 30min"

Phrase: "at 37C,"

Phrase: "and"

Phrase: "the enzyme-inhibitor complex"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   913   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0014432:Enzyme inhibitor [Pharmacologic Substance]
   901   C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]
   827   C1999216:Inhibitor [Qualitative Concept]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "precipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "hydroxyapatite."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0115137:Hydroxyapatite [Biomedical or Dental Material,Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.163: The number of counts bound in the pellet fraction are expressed as a percentage of the total counts. 

Phrase: "The number of counts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "bound in the pellet fraction"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0332297:bound [Spatial Concept]
   760   C0441436:Pellet [Manufactured Object]
   760   C0993610:Pellet [Biomedical or Dental Material]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   760   C1689898:% bound [Quantitative Concept]
   760   C1998480:Pellet [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "are"

Phrase: "expressed as a percentage of the total counts."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   744   C0439157:counts [Quantitative Concept]
   744   C0439165:Percentage [Quantitative Concept]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C1549488:Percentage [Idea or Concept]
   744   C1561533:Percentage [Idea or Concept]
   711 E C0750480:Count [Activity]
   711 E C1705566:Count [Quantitative Concept]
Processing 00000000.tx.164: The results (n=3S.E.) have been normalized relative to maximal inhibitor binding in the presence of reductant (0.1 mM DTT). 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "(n=3S.E.)"

Phrase: "have"

Phrase: "been"

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "relative to maximal inhibitor binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of reductant"

Phrase: "(0.1 mM DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.165: [View Larger Version of this Image (23K GIF file)] DISCUSSION In this study, we have confirmed that both recombinant and tissue-derived EP24.15 activity is markedly increased in the presence of a reducing agent. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(23K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] DISCUSSION In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557061:Discussion [Therapeutic or Preventive Procedure]
   770   C2584313:Discussion [Social Behavior]

Phrase: "we"

Phrase: "have"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "both recombinant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514798:recombinant [Organism]

Phrase: "and"

Phrase: "tissue-derived EP24.15 activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   866   C1150171:endopeptidase activity [Molecular Function]
   791   C0205177:Activity [Functional Concept]
   791   C0439167:% activity [Quantitative Concept]
   791   C0441655:Activity [Activity]
   791   C1561536:*Activity [Idea or Concept]
   708   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "increased in the presence of a reducing agent."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0376446:reducing agent [Indicator, Reagent, or Diagnostic Aid]
   744   C0205217:Increased [Quantitative Concept]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0392756:Reducing [Qualitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C0450442:Agent [Chemical Viewed Functionally]
   744   C1254351:Agent [Pharmacologic Substance]
   744   C1521826:Agent [Intellectual Product]
Processing 00000000.tx.166: We have also shown that both purified recombinant and tissue extracts of native EP24.15 form multimers of approximately 150,240,and >300 kDa through intermolecular disulfide bridges, which upon reduction return EP24.15 to a monomeric form. 

Phrase: "We"

Phrase: "have"

Phrase: "also"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "both purified recombinant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514798:recombinant [Organism]

Phrase: "and"

Phrase: "tissue extracts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040291:Tissue Extracts [Biologically Active Substance]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   827   C2828366:Extract [Substance]

Phrase: "of native EP24.15 form multimers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C1979934:Multimers [Chemical Viewed Structurally]
   708   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "of approximately 150,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332232:Approximately [Qualitative Concept]

Phrase: "240,"

Phrase: "and >"

Phrase: "300 kDa through intermolecular disulfide bridges,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1532717:kDa [Quantitative Concept]

Phrase: "which upon reduction return EP24.15"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   824   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   777   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   739   C0301630:Reduction [Natural Phenomenon or Process]
   739   C0332156:Return [Qualitative Concept]
   739   C0392756:Reduction [Qualitative Concept]
   739   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "to a monomeric form."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]
Processing 00000000.tx.167: The formation of these multimers is a rapid dynamic equilibrium process as can be seen by the rapid reformation of the multimers upon the removal of reducing agent. 

Phrase: "The formation of these multimers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "a rapid dynamic equilibrium process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1184743:Process [Body Part, Organ, or Organ Component]
   812   C1522240:Process [Phenomenon or Process]

Phrase: "as"

Phrase: "can"

Phrase: "be"

Phrase: "seen by the rapid reformation of the multimers"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   744   C0205397:Seen [Qualitative Concept]
   744   C0439831:Rapid [Qualitative Concept]
   744   C1979934:Multimers [Chemical Viewed Structurally]
   711 E C0042789:see [Organism Function]
   711 E C1947903:See [Activity]

Phrase: "upon the removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015252:Removal [Therapeutic or Preventive Procedure]
  1000   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "of reducing agent."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0376446:reducing agent [Indicator, Reagent, or Diagnostic Aid]
   861   C0392756:Reducing [Qualitative Concept]
   861   C0450442:Agent [Chemical Viewed Functionally]
   861   C1254351:Agent [Pharmacologic Substance]
   861   C1521826:Agent [Intellectual Product]
Processing 00000000.tx.168: In addition we have used dynamic light scattering, a spectroscopic technique, to determine the distribution of reduced and non-reduced EP24.15 particle size in solution. 

Phrase: "In addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "have"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "dynamic light scattering,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1882368:Dynamic Light Scattering [Laboratory Procedure]
   901   C0596837:Light Scattering [Phenomenon or Process]
   827   C0023693:Light [Natural Phenomenon or Process]
   827   C0439742:Scattering [Spatial Concept]
   827   C0729333:Dynamic [Functional Concept]
   827   C1306462:Light [Functional Concept]
   827   C1881376:Light [Qualitative Concept]

Phrase: "a spectroscopic technique,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449851:Technique [Functional Concept]
   777 E C0025664:techniques [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the distribution of reduced"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "non-reduced EP24.15 particle size"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0030608:Particle Size [Quantitative Concept]
   790   C0456389:size [Spatial Concept]
   790   C0597177:Particle [Chemical Viewed Structurally]

Phrase: "in solution."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037633:Solution [Substance]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.169: The molecular weight is resolved from the hydrodynamic radius of the particle, and the range of dispersity is reflected in the standard deviation of the radius (24). 

Phrase: "The molecular weight"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0026385:Molecular Weight [Quantitative Concept]
   861   C0005910:weight [Organism Attribute]
   861   C0043100:Weight [Quantitative Concept]
   861   C1305866:weight [Diagnostic Procedure]
   861   C1521991:Molecular [Qualitative Concept]
   861   C1705104:Weight [Idea or Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "is"

Phrase: "resolved from the hydrodynamic radius of the particle,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0034627:Radius [Body Part, Organ, or Organ Component]
   744   C0597177:Particle [Chemical Viewed Structurally]
   744   C1279083:Radius [Body Part, Organ, or Organ Component]
   744   C1306504:Radius [Quantitative Concept]
   744   C1514893:Resolved [Idea or Concept]
   744   C2699488:Resolved [Conceptual Entity]
   744   C2936194:Hydrodynamic [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "the range of dispersity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514721:Range [Quantitative Concept]
   770   C2348147:Range [Quantitative Concept]
   770   C3542016:Range [Intellectual Product]

Phrase: "is"

Phrase: "reflected in the standard deviation of the radius"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0871420:Standard deviation [Quantitative Concept]
   744   C0012727:Deviation [Spatial Concept]
   744   C0034627:Radius [Body Part, Organ, or Organ Component]
   744   C0205419:Deviation [Qualitative Concept]
   744   C0558058:reflected [Mental Process]
   744   C1279083:Radius [Body Part, Organ, or Organ Component]
   744   C1306504:Radius [Quantitative Concept]
   744   C1442989:Standard [Qualitative Concept]
   744   C1705236:Deviation [Finding]
   744   C2828392:Standard [Intellectual Product]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.170: The calculated molecular mass of the reduced samples and the triple Cys mutant (DTT) are within 20% of the apparent molecular mass of EP24.15 (75kDa), and their radius sizes are almost identical. 

Phrase: "The calculated molecular mass of the reduced samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   744   C0577559:Mass [Finding]
   744   C1306372:*Mass [Quantitative Concept]

Phrase: "and"

Phrase: "the triple Cys mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(DTT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "are within 20% of the apparent molecular mass"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   744   C0577559:Mass [Finding]
   744   C0750489:apparent [Idea or Concept]
   744   C1306372:*Mass [Quantitative Concept]
   744   C1521991:Molecular [Qualitative Concept]
   744   C1551058:Are [Quantitative Concept]

Phrase: "of EP24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(75kDa"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "their radius sizes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:SIZES [Spatial Concept]

Phrase: "are"

Phrase: "almost identical."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.171: However, under non-reducing conditions the wild-type protein has a radius 2-3 times greater than that of the monomer and an increased calculated molecular weight confirming the formation of aggregates. 

Phrase: "However,"

Phrase: "under non-reducing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Reducing [Qualitative Concept]
   861   C1518422:Non [Functional Concept]

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "the wild-type protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "has"

Phrase: "a radius 2-3 times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0040223:times [Temporal Concept]
   812   C1632851:Times [Quantitative Concept]
   779 E C3541383:Time [Temporal Concept]
   741 E C0442043:Temporal [Spatial Concept]
   741 E C2362314:Temporal [Temporal Concept]

Phrase: "greater than that of the monomer"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0439093:Greater Than [Quantitative Concept]
   753   C0443228:greater [Quantitative Concept]
   753   C1704243:Greater [Quantitative Concept]
   719 E C0549177:Great [Quantitative Concept]

Phrase: "and"

Phrase: "an increased calculated molecular weight"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   902   C0043094:Increased weight [Finding]
   861   C0026385:Molecular Weight [Quantitative Concept]
   812   C0005910:weight [Organism Attribute]
   812   C0043100:Weight [Quantitative Concept]
   812   C1305866:weight [Diagnostic Procedure]
   812   C1521991:Molecular [Qualitative Concept]
   812   C1705104:Weight [Idea or Concept]
   741 E C0567416:Molecule [Substance]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the formation of aggregates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]
Processing 00000000.tx.172: Furthermore, we have demonstrated that inhibitor access to the catalytic site appears restricted when EP24.15 is multimerized in that inhibitor binding only occurs in the monomeric form. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that inhibitor access to the catalytic site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0589360:access site [Spatial Concept]
   748   C0444454:Access [Spatial Concept]
   748   C1554204:access [Idea or Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "restricted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443288:Restricted [Functional Concept]

Phrase: "when"

Phrase: "EP24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "is"

Phrase: "multimerized in"

Phrase: "that inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "occurs in the monomeric form."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.173: Thus, the observation that access to the particular cysteine residues involved may be restricted, along with the dynamic nature of these interactions, may help explain the ambiguous data obtained for the inhibition of EP24.15 by alkylating and other thiol-blocking agents. 

Phrase: "Thus,"

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that access to the particular cysteine residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0444454:Access [Spatial Concept]
   748   C1554204:access [Idea or Concept]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "restricted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443288:Restricted [Functional Concept]

Phrase: ","

Phrase: "along with the dynamic nature"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "of these interactions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "may"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "explain"

Phrase: "the ambiguous data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "obtained for the inhibition of EP24.15"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   813   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   772   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   754   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0021467:Inhibition [Mental Process]
   738   C0021469:Inhibition [Molecular Function]
   738   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   738   C1301820:Obtained [Functional Concept]
   738   C1628982:% inhibition [Quantitative Concept]
   738   C3463820:Inhibition [Activity]
   704 E C1706701:Obtain [Activity]

Phrase: "by alkylating"

Phrase: "and"

Phrase: "other thiol-blocking agents."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   827   C0233660:Blocking [Mental or Behavioral Dysfunction]
   827   C0332206:Blocking [Functional Concept]
   793 E C0028778:Block [Pathologic Function]
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]
   793 E C1533157:Block [Substance]
   793 E C1706084:Block [Geographic Area]
   793 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.174: Through systematic site-directed mutagenesis we have shown that the closely located cysteine residues 246,248,and 253are likely involved in forming these intermolecular disulfide bridges and hence involved in the thiol activation of EP24.15. 

Phrase: "Through systematic site-directed mutagenesis"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   923   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   812   C0079866:Mutagenesis [Molecular Function]
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]
   812   C3146302:Mutagenesis [Laboratory Procedure]
   779   C0439851:Direct [Qualitative Concept]
   779   C1947931:Direct [Qualitative Concept]
   741 E C0439755:Directions [Spatial Concept]
   741 E C0449738:Direction [Spatial Concept]

Phrase: "we"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the closely located cysteine residues 246,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1709915:Residue [Conceptual Entity]
   771   C1882936:RESIDUE [Phenomenon or Process]
   721 E C1609982:Residual [Qualitative Concept]

Phrase: "248,"

Phrase: "and"

Phrase: "253are likely"

Phrase: "involved in forming"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205431:Forming [Functional Concept]
   790   C1314939:Involved [Functional Concept]
   790   C1522492:Forming [Functional Concept]
   756 E C0348078:Form [Qualitative Concept]
   756 E C0376315:Form [Manufactured Object]

Phrase: "these intermolecular disulfide bridges"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012771:disulfide [Chemical Viewed Structurally]
   827   C0456378:bridges [Medical Device]

Phrase: "and"

Phrase: "hence"

Phrase: "involved in the thiol activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0038734:thiol [Organic Chemical]
   760   C1314939:Involved [Functional Concept]
   760   C1879547:Activation [Activity]

Phrase: "of EP24.15."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
Processing 00000000.tx.175: Although Cys-248 is conserved in EP24.16, a closely related but non-thiol-activated peptidase, it is presumably acting in a cooperative manner with the EP24.15 unique Cys-246 and Cys-253 to confer the thiol dependence. 

Phrase: "Although"

Phrase: "Cys-248"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "conserved in EP24.16,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   855   C0286406:endopeptidase 3.4.24.16 [Amino Acid, Peptide, or Protein,Enzyme]
           endopeptidase 24.16
   770   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "a closely"

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "but"

Phrase: "non-thiol-activated peptidase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1947941:Peptidase [Enzyme]

Phrase: "it"

Phrase: "is"

Phrase: "presumably"

Phrase: "acting in a cooperative manner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0679729:cooperative [Organization]
   726   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "with the EP24.15 unique Cys-246"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   858   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   817   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   807   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   791   C1710548:Unique [Qualitative Concept]

Phrase: "and"

Phrase: "Cys-253 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "confer"

Phrase: "the thiol dependence."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0011546:Dependence [Mental Process]
   861   C0439857:Dependence [Mental or Behavioral Dysfunction]
   861   C2698668:DEPENDENCE [Regulation or Law]
   789 E C0851827:Dependent [Qualitative Concept]
   789 E C1701901:Dependent [Qualitative Concept]
   789 E C3244310:dependent [Functional Concept]
   761 E C1546937:Dependency [Idea or Concept]
Processing 00000000.tx.176: These results are in agreement with the suggestion of Barrett et al. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are in agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0680240:Agreement [Social Behavior]
   790   C1551058:Are [Quantitative Concept]

Phrase: "with the suggestion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038659:Suggestion [Idea or Concept]
  1000   C1705535:suggestion [Idea or Concept]

Phrase: "of Barrett et al."
Processing 00000000.tx.177: (25) that Cys-246 and Cys-253 were likely candidates for a role in the thiol activation of EP24.15, reflecting both their close location and sole appearance in EP24.15 upon sequence comparison with mitochondrial oligopeptidase. 

Phrase: "(25"

Phrase: ")"

Phrase: "that Cys-246"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Cys-253"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "likely candidates for a role"

Phrase: "in the thiol activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "of EP24.15,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "both their close location"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450429:Location [Spatial Concept]
   861   C1515974:Location [Body Location or Region]

Phrase: "and"

Phrase: "sole appearance in EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0233426:Appearance [Organism Attribute]
   742   C0700364:Appearance [Qualitative Concept]

Phrase: "upon sequence comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707455:Comparison [Activity]

Phrase: "with mitochondrial oligopeptidase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0069437:oligopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.178: Our findings, however, are not consistent with the hypothesis that the cysteine, which is 5residues from the catalytic center (Cys-483) and also present in EP24.16, is involved in the thiol activation (8). 

Phrase: "Our findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "however,"

Phrase: "are"

Phrase: "not consistent with the hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that"

Phrase: "the cysteine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "is"

Phrase: "5residues from the catalytic center"

Phrase: "(Cys-483"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "and"

Phrase: "also"

Phrase: "present in EP24.16,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   855   C0286406:endopeptidase 3.4.24.16 [Amino Acid, Peptide, or Protein,Enzyme]
           endopeptidase 24.16
   770   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0150312:Present [Quantitative Concept]
   744   C0449450:Present [Idea or Concept]

Phrase: "is"

Phrase: "involved in the thiol activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0038734:thiol [Organic Chemical]
   760   C1314939:Involved [Functional Concept]
   760   C1879547:Activation [Activity]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.179: We thus propose a mechanism for the thiol activation of EP24.15 where under oxidative conditions the enzyme aggregates through the formation of intermolecular disulfide bridges involving cysteine residues 246,248,and 253.

Phrase: "We thus"

Phrase: "propose"

Phrase: "a mechanism for the thiol activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "of EP24.15 where"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   911   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   829   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "under oxidative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0311404:Oxidative [Functional Concept]

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "aggregates through the formation of intermolecular disulfide bridges"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0012771:disulfide [Chemical Viewed Structurally]
   744   C0205418:Aggregate [Qualitative Concept]
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C0456378:bridges [Medical Device]
   744   C1522492:Formation [Functional Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "cysteine residues 246,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "248,"

Phrase: "and"

Phrase: "253."
Processing 00000000.tx.180: This multimeric form is inactive, suggesting that the disulfide bridging between one or more EP24.15 molecules blocks substrate access. 

Phrase: "This multimeric form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "is"

Phrase: "inactive,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205254:Inactive [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the disulfide bridging between one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0456378:Bridge [Medical Device]

Phrase: "or"

Phrase: "more EP24.15 molecules"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0567416:molecules [Substance]
   723   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   710 E C1521991:Molecular [Qualitative Concept]
   703   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "substrate access."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0444454:Access [Spatial Concept]
   861   C1554204:access [Idea or Concept]
Processing 00000000.tx.181: The addition of a reductant disrupts the disulfide bridges by monomerizing the enzyme and thus removing the restriction on access of substrate to the catalytic site and therefore activating EP24.15. 

Phrase: "The addition of a reductant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "disrupts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "the disulfide bridges by monomerizing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0012771:disulfide [Chemical Viewed Structurally]
   760   C0456378:bridges [Medical Device]

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "removing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0849355:remove [Qualitative Concept]
   966   C1883720:Remove [Activity]
   966   C3244314:remove [Functional Concept]

Phrase: "the restriction on access of substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443288:Restriction [Functional Concept]

Phrase: "to the catalytic site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0205681:Catalytic Site [Functional Concept]
  1000   C0600499:catalytic site [Amino Acid Sequence]
   861   C0007382:Catalytic [Natural Phenomenon or Process]
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "therefore"

Phrase: "activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "EP24.15."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
Processing 00000000.tx.182: The formation of multimers through disulfide linkages involving other cysteines cannot be dismissed. 

Phrase: "The formation of multimers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "through disulfide linkages"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1511997:Disulfide Linkage [Amino Acid Sequence]
   827   C0023745:linkage [Molecular Function]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "other cysteines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010654:cysteines [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cannot"

Phrase: "be"

Phrase: "dismissed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348301:Dismissed [Activity]
Processing 00000000.tx.183: However, only when the disulfide linkages involve Cys-246, -248,and -253is the catalytic activity of EP24.15 affected. 

Phrase: "However,"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "when"

Phrase: "the disulfide linkages"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1511997:Disulfide Linkage [Amino Acid Sequence]
   827   C0023745:linkage [Molecular Function]

Phrase: "involve"

Phrase: "Cys-246, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "248,"

Phrase: "and -"

Phrase: "253is"

Phrase: "the catalytic activity of EP24.15"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0243102:catalytic activity [Molecular Function]
   760   C1264638:Catalytic activity [Functional Concept]
   760   C1547012:*Catalytic Activity [Quantitative Concept]
   757   C1150171:endopeptidase activity [Molecular Function]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "affected."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]
Processing 00000000.tx.184: It is of interest to note that Cys-246, -248,and -253lie within a region of charged residues (Fig. 5) consistent with the concept that this part of the molecule may be located at or near the enzyme surface. 

Phrase: "It"

Phrase: "is of interest to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0543488:Interest [Mental Process]

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that Cys-246, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "248,"

Phrase: "and -"

Phrase: "253lie within a region of charged residues"

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "consistent with the concept"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that"

Phrase: "this part of the molecule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1292711:Part of [Spatial Concept]
   760   C0449719:Part [Spatial Concept]
   760   C1709471:Part [Quantitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "located at"

Phrase: "or near the enzyme surface."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0205148:Surface [Spatial Concept]
Processing 00000000.tx.185: To our knowledge, this is the first report of a peptidase being activated in such a manner, i.e. the reduction of multimers rather than their formation to promote activation. 

Phrase: "To our knowledge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "this"

Phrase: "is"

Phrase: "the first report of a peptidase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0684224:Report [Intellectual Product]
   753   C0700287:Report [Health Care Activity]
   753   C3273238:Report [Intellectual Product]

Phrase: "being"

Phrase: "activated in such"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "a manner,"

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the reduction of multimers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "rather than"

Phrase: "their formation to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]
Processing 00000000.tx.186: However, it is not the first report of thiol activation in which disulfides blocking the active site are reduced. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the first report of thiol activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0684224:Report [Intellectual Product]
   753   C0700287:Report [Health Care Activity]
   753   C3273238:Report [Intellectual Product]

Phrase: "in which disulfides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012771:Disulfides [Chemical Viewed Structurally]

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "reduced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]
Processing 00000000.tx.187: Plant NADP-dependent malate dehydrogenase has been shown to be activated through thiol/disulfide interchange with reduced thioredoxin such that disulfide reduction at the N terminus leads to a conformational change to the active site, whereas the C-terminal end, which shields access to the catalytic residues, is opened by this reduction (26). 

Phrase: "Plant NADP-dependent malate dehydrogenase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   888   C0065559:NADP-Malate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0027312:NADP Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0024544:Malate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0220873:malate [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "activated through thiol/disulfide interchange"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0012771:disulfide [Chemical Viewed Structurally]
   760   C0038734:thiol [Organic Chemical]
   760   C1879547:Activated [Activity]
   726 E C1515877:Activate [Functional Concept]

Phrase: "with reduced thioredoxin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "such"

Phrase: "that disulfide reduction at the N terminus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C2267001:Disulfide Reduction [Molecular Function]
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "leads to a conformational change"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0301641:Conformational change [Molecular Function]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0181586:leads [Medical Device]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1705241:Change [Quantitative Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to the active site,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "whereas"

Phrase: "the C-terminal end,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0444930:End [Spatial Concept]
   827   C2746065:End [Temporal Concept]
   734   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: "which"

Phrase: "shields"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183251:Shield [Medical Device]
  1000   C1705198:Shield [Medical Device]

Phrase: "access to the catalytic residues,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0444454:Access [Spatial Concept]
   760   C1554204:access [Idea or Concept]

Phrase: "is"

Phrase: "opened by this reduction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   802   C0185373:Open # reduction [Therapeutic or Preventive Procedure]
   802   C2370853:Open reduction [Therapeutic or Preventive Procedure]
   770   C0175566:Opened [Spatial Concept]
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.188: The physiological significance of the thiol activation of EP24.15 both intra- and extracellularly is still to be elucidated. 

Phrase: "The physiological significance of the thiol activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237881:Significance [Quantitative Concept]
   748   C0750502:Significance [Idea or Concept]

Phrase: "of EP24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "both intra-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0347985:Intra [Temporal Concept]

Phrase: "and"

Phrase: "extracellularly"

Phrase: "is"

Phrase: "still to"

Phrase: "be"

Phrase: "elucidated."
Processing 00000000.tx.189: We have examined the catalytic activity of rat EP24.15 in testes extract on both reduced and non-reduced size exclusion chromatography and have found a single peak of activity under reducing conditions corresponding to the monomeric form, whereas the activity is eluted in a higher molecular mass form when non-reduced. 

Phrase: "We"

Phrase: "have"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the catalytic activity of rat EP24.15"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   756   C0243102:catalytic activity [Molecular Function]
   756   C1264638:Catalytic activity [Functional Concept]
   756   C1547012:*Catalytic Activity [Quantitative Concept]
   754   C1150171:endopeptidase activity [Molecular Function]
   738   C0205177:Activity [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1561536:*Activity [Idea or Concept]

Phrase: "in testes"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0021358:Testes [Body Part, Organ, or Organ Component]
  1000   C0039597:Testes [Body Part, Organ, or Organ Component]
   966 E C0228018:teste [Body Part, Organ, or Organ Component]
   966 E C1278981:Testis [Body Part, Organ, or Organ Component]
   900 E C0205070:Testicular [Spatial Concept]
   884 E C1284096:Testicle [Body Part, Organ, or Organ Component]

Phrase: "extract on both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2828366:Extract [Substance]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "and"

Phrase: "non-reduced size exclusion chromatography"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   884   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
   884   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   804   C0008550:Chromatography [Laboratory Procedure]
   804   C0456389:size [Spatial Concept]
   804   C0680251:EXCLUSION [Functional Concept]
   804   C2828389:Exclusion [Activity]
   704 E C0302647:chromatograph [Medical Device]

Phrase: "and"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "a single peak of activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0444505:Peak [Quantitative Concept]

Phrase: "under reducing conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "corresponding to the monomeric form,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "whereas"

Phrase: "the activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "eluted in a higher molecular mass form"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C0577559:Mass [Finding]
   748   C1306372:*Mass [Quantitative Concept]
   748   C1521991:Molecular [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   714   C0205250:High [Qualitative Concept]
   714   C1299351:High [Qualitative Concept]
   714   C2700149:HIGH [Intellectual Product]

Phrase: "when"

Phrase: "non-reduced."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Reduced [Qualitative Concept]
   861   C1518422:Non [Functional Concept]
Processing 00000000.tx.190: In addition, we have examined the activation of EP24.15 over a range of protein concentrations and exclude the possibility that multimer formation only occurs at high concentrations of recombinant protein. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "have"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the activation of EP24.15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1879547:Activation [Activity]

Phrase: "over a range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "of protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that multimer formation only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "occurs at high concentrations of recombinant protein."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   757   C0427716:Protein concentration [Laboratory Procedure]
   757   C1304757:Protein concentration [Laboratory or Test Result]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0086045:Concentrations [Mental Process]
   748   C0205250:High [Qualitative Concept]
   748   C1299351:High [Qualitative Concept]
   748   C1514798:recombinant [Organism]
   748   C1709305:Occur [Activity]
   748   C2700149:HIGH [Intellectual Product]
   748   C2745955:OCCUR [Temporal Concept]
   714 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.191: Indeed, we find similar or even greater thiol activation at lower concentrations (<0.1 M) of EP24.15, similar to those that we calculate exist, for example, in the cell nucleus.2 Thus nuclear EP 24.15activity could be controlled by the well documented (27-29) regulated changes in nuclear redox potential. 

Phrase: "Indeed,"

Phrase: "we"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "or"

Phrase: "even greater thiol activation at lower concentrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1879547:Activation [Activity]

Phrase: "("

Phrase: "<0.1"

Phrase: "M) of EP24.15,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   855   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0168944:M 15 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "that"

Phrase: "we"

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: ","

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "in the cell nucleus.2 Thus nuclear EP 24.15activity"

Phrase: "could"

Phrase: "be"

Phrase: "controlled by the well documented"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   806   C0332298:Controlled by [Functional Concept]
   760   C0205170:Well [Qualitative Concept]
   760   C1301725:Documented [Health Care Activity]
   760   C1609436:documented [Idea or Concept]
   760   C2587213:Controlled [Functional Concept]
   760   C3146287:Well [Manufactured Object]
   726 E C0243148:control [Qualitative Concept]
   726 E C1301746:document [Intellectual Product]
   726 E C1547673:Document [Intellectual Product]
   726 E C1550141:Control [Substance]
   726 E C1882979:Control [Conceptual Entity]
   726 E C3274648:Control [Qualitative Concept]

Phrase: "(27-29"

Phrase: ")"

Phrase: "regulated changes in nuclear redox potential."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.192: In the cell cytosol we would predict that EP24.15 is largely in the monomeric form, reflecting the general reductive environment of the cytosolic compartment. 

Phrase: "In the cell cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1383501:Cytosol [Cell Component]

Phrase: "we"

Phrase: "would"

Phrase: "predict"

Phrase: "that EP24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "is"

Phrase: "largely in the monomeric form,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "the general reductive environment of the cytosolic compartment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0014406:Environment [Spatial Concept]
Processing 00000000.tx.193: At the cell surface, however, which is generally oxidative, it is conceivable that enzymes such as the protein disulfide isomerase(s) or thioredoxin (30-32) may influence EP24.15 activity and thus ultimately regulate peptide signal delivery at the cell surface. 

Phrase: "At the cell surface,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]

Phrase: "however,"

Phrase: "which"

Phrase: "is"

Phrase: "generally oxidative,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0311404:Oxidative [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "conceivable"

Phrase: "that enzymes such as the protein disulfide isomerase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0014442:Enzymes [Enzyme,Organic Chemical]
   744   C0014445:enzymes [Functional Concept]

Phrase: "("

Phrase: "s)"

Phrase: "or"

Phrase: "thioredoxin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(30-32"

Phrase: ")"

Phrase: "may"

Phrase: "influence"

Phrase: "EP24.15 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   893   C1150171:endopeptidase activity [Molecular Function]
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]
   744   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "thus ultimately"

Phrase: "regulate"

Phrase: "peptide signal delivery at the cell surface."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0011209:Delivery [Therapeutic or Preventive Procedure]
   748   C0559563:delivery [Finding]
   748   C1705822:Delivery [Activity]
Processing 00000000.tx.194: In conclusion, we have demonstrated that the mechanism by which EP24.15 is activated by thiols likely reflects the conversion of an inactive multimer (where substrate access to the catalytic site is blocked) into an active monomer. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the mechanism by which EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0441712:Mechanism [Functional Concept]
   739   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "activated by thiols likely"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0038734:Thiols [Organic Chemical]
   770   C0332148:Likely [Qualitative Concept]
   770   C0750492:Likely [Idea or Concept]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the conversion of an inactive multimer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439836:Conversion [Functional Concept]

Phrase: "(where substrate access to the catalytic site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0589360:access site [Spatial Concept]
   748   C0444454:Access [Spatial Concept]
   748   C1554204:access [Idea or Concept]

Phrase: "is"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: ")"

Phrase: "into an active monomer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596973:Monomer [Chemical Viewed Structurally]
Processing 00000000.tx.195: This conversion reflects the disruption of intermolecular disulfide bridges involving a cluster of cysteine residues at positions 246,253,and possibly 248of EC 3.4.24.15. 

Phrase: "This conversion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439836:Conversion [Functional Concept]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the disruption of intermolecular disulfide bridges"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332453:Disruption [Functional Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "a cluster of cysteine residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1555715:Cluster [Idea or Concept]
   760   C1704332:Cluster [Quantitative Concept]

Phrase: "at positions 246,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "253,"

Phrase: "and"

Phrase: "possibly 248of EC 3.4.24.15."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   829   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C2362652:Possibly [Qualitative Concept]
Processing 00000000.tx.196: FOOTNOTES * This work was supported by the National Health and Medical Research Council of Australia and National Institutes of Health Grant DK45493 and Endocrine Training Grant T32-DK07645.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by the National Health and Medical Research Council of Australia"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   772   C0027472:National Research Council [Organization]
   759   C1568415:Support of Research [Intellectual Product]
   756   C0079816:Medical Research [Research Activity]
   756   C1556038:Medical Research [Professional or Occupational Group]
   754   C0035176:research supported [Quantitative Concept]
   738   C0004340:Australia [Geographic Area]
   738   C0018684:Health [Idea or Concept]
   738   C0035168:research [Research Activity]
   738   C0205476:Medical [Functional Concept]
   738   C0242481:Research [Research Activity]
   738   C1521721:Supported [Conceptual Entity]
   738   C1551807:Council [Population Group]
   738   C3245503:national [Intellectual Product]
   704 E C0183683:Support [Medical Device]

Phrase: "and"

Phrase: "National Institutes of Health Grant DK45493"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027468:National Institutes of Health [Health Care Related Organization]

Phrase: "and"

Phrase: "Endocrine Training Grant T32-DK07645."
Processing 00000000.tx.197: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.198: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.199: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.200: To whom correspondence should be addressed: Baker Medical Research Inst., P.O. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Baker Medical Research Inst.,"

Phrase: "P.O."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.201: Box 348,Prahran, Victoria 3181,Australia. 

Phrase: "Box 348,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "Prahran,"

Phrase: "Victoria 3181,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042645:Victoria [Geographic Area]
   861   C0997115:Victoria [Plant]

Phrase: "Australia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]
Processing 00000000.tx.202: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.203: 61-3-9522-4373; 

Phrase: "61-3-9522-4373"

Phrase: ";"
Processing 00000000.tx.204: Fax: 61-3-9521-1362; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "61-3-9521-1362"

Phrase: ";"
Processing 00000000.tx.205: E-mail: ian.smith{at}baker.edu.au . 1 The abbreviations used are: EP24.15, endopeptidase EC 3.4.24.15; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "ian.smith{at}baker.edu.au . 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C0541146:AU-1 [Organic Chemical,Pharmacologic Substance]
   795   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
   795   C0238749:Baker [Professional or Occupational Group]
   795   C0554249:Smith [Professional or Occupational Group]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "EP24.15,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "endopeptidase EC 3.4.24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0525439:endopeptidase 3.4.24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   904   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.206: EP24.16, endopeptidase EC 3.4.24.16; 

Phrase: "EP24.16,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0286406:endopeptidase 3.4.24.16 [Amino Acid, Peptide, or Protein,Enzyme]
           endopeptidase 24.16
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "endopeptidase EC 3.4.24.16"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   941   C0286406:endopeptidase 3.4.24.16 [Amino Acid, Peptide, or Protein,Enzyme]
           endopeptidase 24.16
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.207: HPLC, high performance liquid chromatography; 

Phrase: "HPLC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "high performance liquid chromatography"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
  1000   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
  1000   C1579831:High performance liquid chromatography [Functional Concept]
   861   C0008565:Liquid Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C0205250:High [Qualitative Concept]
   812   C0302908:Liquid [Substance]
   812   C0597198:Performance [Individual Behavior]
   812   C1299351:High [Qualitative Concept]
   812   C1304698:Liquid [Finding]
   812   C1546699:Liquid NOS [Intellectual Product]
   812   C1561501:Liquid NOS [Substance]
   812   C1882330:Performance [Activity]
   812   C2700149:HIGH [Intellectual Product]
   712 E C0302647:chromatograph [Medical Device]

Phrase: ";"
Processing 00000000.tx.208: DTT, dithiothreitol; 

Phrase: "DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "dithiothreitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.209: QFS, quenched fluorescent substrate; 

Phrase: "QFS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "quenched fluorescent substrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C1710236:Substrate [Manufactured Object]

Phrase: ";"
Processing 00000000.tx.210: cFP, N-[1-(R,S)-carboxy-3-phenylpropyl]-Ala-Ala-Tyr-paminobenzoate. 

Phrase: "cFP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055162:CFP [Therapeutic or Preventive Procedure]
  1000   C1418482:CFP [Gene or Genome]

Phrase: "N-[1-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "(R,S"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ")-"

Phrase: "carboxy-3-phenylpropyl"

Phrase: "]-Ala-Ala-Tyr-paminobenzoate."
Processing 00000000.tx.211: 2 C. 

Phrase: "2 C."
Processing 00000000.tx.212: N.

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.213: Shrimpton, M.J.

Phrase: "Shrimpton,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.214: Glucksman, R.A.Lew, J.W.Tullai, E.H.

Phrase: "Glucksman,"

Phrase: "R.A.Lew, J.W.Tullai,"

Phrase: "E.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.215: Margulies, J.L.

Phrase: "Margulies,"

Phrase: "J.L."
Processing 00000000.tx.216: Roberts, and A.I.Smith, unpublished observations. 

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "and"

Phrase: "A.I.Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0554249:Smith [Professional or Occupational Group]

Phrase: "unpublished observations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]
Processing 00000000.tx.217: ACKNOWLEDGEMENTS We thank M.

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.218: Fullerton for the preparation of iodonated cFP and Dr. 

Phrase: "Fullerton for the preparation of iodonated cFP"

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.219: Steve Hubbard (NYU) for use of the dynamic light-scattering instrumentation. 

Phrase: "Steve Hubbard"

Phrase: "(NYU"

Phrase: ")"

Phrase: "for use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of the dynamic light-scattering instrumentation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0021632:instrumentation [Qualitative Concept]
   812   C0348000:Instrumentation [Medical Device]
   812   C1704339:Instrumentation [Quantitative Concept]
   756   C1882368:Dynamic Light Scattering [Laboratory Procedure]
Processing 00000000.tx.220: We gratefully acknowledge Drs. 

Phrase: "We gratefully"

Phrase: "acknowledge"

Phrase: "Drs."
Processing 00000000.tx.221: Wally Thomas and Robert Andrews (Baker Institute) for their help and critical evaluation of the manuscript. 

Phrase: "Wally Thomas"

Phrase: "and"

Phrase: "Robert Andrews"

Phrase: "(Baker Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: ")"

Phrase: "for their"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "and"

Phrase: "critical evaluation of the manuscript."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0220825:Evaluation [Functional Concept]
   760   C1261322:Evaluation [Health Care Activity]
Processing 00000000.tx.222: REFERENCES Orlowski, M., Michaud, C., and Chu, T. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Orlowski,"

Phrase: "M."

Phrase: ","

Phrase: "Michaud,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Chu,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.223: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.224: (1983) Eur. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.225: J.

Phrase: "J."
Processing 00000000.tx.226: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.227: 135, 81-88 [Abstract] Dando, P. 

Phrase: "135,"

Phrase: "81-88"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Dando,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.228: M., Brown, M. 

Phrase: "M."

Phrase: ","

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.229: A., and Barrett, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Barrett,"

Phrase: "A."
Processing 00000000.tx.230: J. 

Phrase: "J."
Processing 00000000.tx.231: (1993) Biochem. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.232: J. 

Phrase: "J."
Processing 00000000.tx.233: 294, 451-457 [Medline] [OrderarticleviaInfotrieve] Papastoitsis, G., Siman, R., Scott, R., and Abraham, C. 

Phrase: "294,"

Phrase: "451-457"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Papastoitsis,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Siman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Scott,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Abraham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442982:Abraham [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.234: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.235: (1994) Biochemistry 33, 192-199 [Medline] [OrderarticleviaInfotrieve] McDermott, J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Biochemistry 33,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "192-199"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] McDermott,"

Phrase: "J."
Processing 00000000.tx.236: R., Biggins, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Biggins,"

Phrase: "J."
Processing 00000000.tx.237: A., and Gibson, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Gibson,"

Phrase: "A."
Processing 00000000.tx.238: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.239: (1992) Biochem. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.240: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.241: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.242: Commun. 

Phrase: "Commun."
Processing 00000000.tx.243: 185, 746-753 [Medline] [OrderarticleviaInfotrieve] Acker, G. 

Phrase: "185,"

Phrase: "746-753"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Acker,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.244: R., Molineaux, C., and Orlowski, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Molineaux,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Orlowski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.245: (1987) J. 

Phrase: "(1987"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.246: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.247: 48, 284-292 [Medline] [OrderarticleviaInfotrieve] Chu, T. 

Phrase: "48,"

Phrase: "284-292"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Chu,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.248: G., and Orlowski, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Orlowski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.249: (1985) Endocrinology 116, 1418-1425 [Abstract] Chu, T. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Endocrinology 116,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: "1418-1425"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Chu,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.250: G., and Orlowski, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Orlowski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.251: (1984) Biochemistry 23, 3598-3603 [Medline] [OrderarticleviaInfotrieve] Pierotti, A., Dong, K.-W., Glucksman, M. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Biochemistry 23,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005477:Biochemistry [Occupation or Discipline]
   861   C0450348:23 [Quantitative Concept]

Phrase: "3598-3603"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pierotti,"

Phrase: "A.,"

Phrase: "Dong,"

Phrase: "K.-W., Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.252: J., Orlowski, M., and Roberts, J. 

Phrase: "J.,"

Phrase: "Orlowski,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.253: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.254: (1990) Biochemistry 29, 10323-10329 [Medline] [OrderarticleviaInfotrieve] ; Correction (1994) Biochemistry 33, 622 Jongeneel, C. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Biochemistry 29,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "10323-10329"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

Phrase: "; Correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "(1994"

Phrase: ")"

Phrase: "Biochemistry 33,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "622 Jongeneel,"

Phrase: "C."
Processing 00000000.tx.255: V., Bouvier, J., and Bairoch, A. 

Phrase: "V., Bouvier,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Bairoch,"

Phrase: "A."
Processing 00000000.tx.256: (1989) FEBS Lett. 

Phrase: "(1989"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.257: 242, 211-214 [CrossRef][Medline] [OrderarticleviaInfotrieve] Orlowski, M., Reznik, S., Ayala, J., and Pierotti, A. 

Phrase: "242,"

Phrase: "211-214"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Orlowski,"

Phrase: "M."

Phrase: ","

Phrase: "Reznik,"

Phrase: "S."

Phrase: ","

Phrase: "Ayala,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Pierotti,"

Phrase: "A."
Processing 00000000.tx.258: (1989) Biochem. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.259: J. 

Phrase: "J."
Processing 00000000.tx.260: 261, 951-958 [Medline] [OrderarticleviaInfotrieve] Tisljar, U., and Barrett, A. 

Phrase: "261,"

Phrase: "951-958"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tisljar,"

Phrase: "U.,"

Phrase: "and"

Phrase: "Barrett,"

Phrase: "A."
Processing 00000000.tx.261: J. 

Phrase: "J."
Processing 00000000.tx.262: (1990) Biochem. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.263: J. 

Phrase: "J."
Processing 00000000.tx.264: 267, 531-533 [Medline] [OrderarticleviaInfotrieve] Lew, R. 

Phrase: "267,"

Phrase: "531-533"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lew,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.265: A., Hey, N. 

Phrase: "A.,"

Phrase: "Hey,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.266: J., Tetaz, T. 

Phrase: "J.,"

Phrase: "Tetaz,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.267: J., Glucksman, M. 

Phrase: "J.,"

Phrase: "Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.268: J., Roberts, J. 

Phrase: "J.,"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.269: L., and Smith, A. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A."
Processing 00000000.tx.270: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.271: (1995) Biochem. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.272: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.273: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.274: Commun. 

Phrase: "Commun."
Processing 00000000.tx.275: 209, 788-795 [CrossRef][Medline] [OrderarticleviaInfotrieve] Morales, T. 

Phrase: "209,"

Phrase: "788-795"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Morales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026530:Morales [Individual Behavior]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.276: I., and Woessner, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Woessner,"

Phrase: "J."
Processing 00000000.tx.277: F., Jr. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.278: (1977) J. 

Phrase: "(1977"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.279: Biol. 

Phrase: "Biol."
Processing 00000000.tx.280: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.281: 252, 4855-4860 [Abstract] Barrett, A. 

Phrase: "252,"

Phrase: "4855-4860"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Barrett,"

Phrase: "A."
Processing 00000000.tx.282: J., and Brown, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.283: A. 

Phrase: "A."
Processing 00000000.tx.284: (1990) Biochem. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.285: J. 

Phrase: "J."
Processing 00000000.tx.286: 271, 701-706 [Medline] [OrderarticleviaInfotrieve] Tisljar, U., and Barrett, A. 

Phrase: "271,"

Phrase: "701-706"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tisljar,"

Phrase: "U.,"

Phrase: "and"

Phrase: "Barrett,"

Phrase: "A."
Processing 00000000.tx.287: J. 

Phrase: "J."
Processing 00000000.tx.288: (1989) Arch. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.289: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.290: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.291: 274, 138-144 [Medline] [OrderarticleviaInfotrieve] Hyrcyna, C. 

Phrase: "274,"

Phrase: "138-144"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hyrcyna,"

Phrase: "C."
Processing 00000000.tx.292: A., and Clarke, S. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Clarke,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.293: (1993) Biochemistry 32, 11293-11301 [Medline] [OrderarticleviaInfotrieve] Tisljar, U. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Biochemistry 32,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "11293-11301"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tisljar,"

Phrase: "U."
Processing 00000000.tx.294: (1993) Biol. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Biol."
Processing 00000000.tx.295: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.296: Hoppe-Seyler 374, 91-100 [Medline] [OrderarticleviaInfotrieve] Dauch, P., Vincent, J.-P., and Checler, F. 

Phrase: "Hoppe-Seyler 374,"

Phrase: "91-100"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Dauch,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vincent,"

Phrase: "J.-P.,"

Phrase: "and"

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.297: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.298: Biol. 

Phrase: "Biol."
Processing 00000000.tx.299: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.300: 270, 27266-27271 [Abstract/Free FullText] Tisljar, U., Knight, C. 

Phrase: "270,"

Phrase: "27266-27271"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tisljar,"

Phrase: "U.,"

Phrase: "Knight,"

Phrase: "C."
Processing 00000000.tx.301: G., and Barrett, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Barrett,"

Phrase: "A."
Processing 00000000.tx.302: J. 

Phrase: "J."
Processing 00000000.tx.303: (1990) Anal. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.304: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.305: 186, 112-115 [Medline] [OrderarticleviaInfotrieve] Gomori, G. 

Phrase: "186,"

Phrase: "112-115"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gomori,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.306: (1955) Methods Enzymol. 

Phrase: "(1955"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.307: 1, 138-146 Salacinski, P. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "138-146 Salacinski,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.308: R.P., McLean, C., Sykes, J. 

Phrase: "R.P.,"

Phrase: "McLean,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Sykes,"

Phrase: "J."
Processing 00000000.tx.309: E.C., Clement-Jones, V. 

Phrase: "E.C.,"

Phrase: "Clement-Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443013:Jones [Intellectual Product]

Phrase: "V."
Processing 00000000.tx.310: V., and Lowry, P. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Lowry,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.311: J. 

Phrase: "J."
Processing 00000000.tx.312: (1981) Anal. 

Phrase: "(1981"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.313: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.314: 117, 136-146 [Medline] [OrderarticleviaInfotrieve] Glucksman, M. 

Phrase: "117,"

Phrase: "136-146"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.315: J., and Roberts, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.316: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.317: (1995) Methods Neurosci. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Methods Neurosci."
Processing 00000000.tx.318: 43, 296-316 Bradford, M. 

Phrase: "43,"

Phrase: "296-316 Bradford,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.319: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.320: (1976) Anal. 

Phrase: "(1976"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.321: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.322: 72, 248-254 [CrossRef][Medline] [OrderarticleviaInfotrieve] Ferre-D'Amare, A. 

Phrase: "72,"

Phrase: "248-254"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ferre-"

Phrase: "D'"

Phrase: "Amare,"

Phrase: "A."
Processing 00000000.tx.323: R., and Burley, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Burley,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.324: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.325: (1994) Structure (Lond.) 

Phrase: "(1994"

Phrase: ")"

Phrase: "Structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "(Lond."

Phrase: ")"
Processing 00000000.tx.326: 2, 357-359 [Medline] [OrderarticleviaInfotrieve] Barrett, A. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "357-359"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Barrett,"

Phrase: "A."
Processing 00000000.tx.327: J., Brown, M. 

Phrase: "J.,"

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.328: A., Dando, P. 

Phrase: "A.,"

Phrase: "Dando,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.329: M., Knight, C. 

Phrase: "M."

Phrase: ","

Phrase: "Knight,"

Phrase: "C."
Processing 00000000.tx.330: G., McKie, N., Rawlings, N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "McKie,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Rawlings,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.331: D., and Serizawa, A. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Serizawa,"

Phrase: "A."
Processing 00000000.tx.332: (1995) Methods Enzymol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.333: 248, 529-556 [Medline] [OrderarticleviaInfotrieve] Issakidis, E., Lemaire, M., Decottignies, P., Jacquot, J.-P., and Miginiac-Maslow, M. 

Phrase: "248,"

Phrase: "529-556"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Issakidis,"

Phrase: "E.,"

Phrase: "Lemaire,"

Phrase: "M."

Phrase: ","

Phrase: "Decottignies,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Jacquot,"

Phrase: "J.-P.,"

Phrase: "and"

Phrase: "Miginiac-Maslow,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.334: (1996) FEBS Lett. 

Phrase: "(1996"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.335: 392, 121-124 [CrossRef][Medline] [OrderarticleviaInfotrieve] Bannister, A. 

Phrase: "392,"

Phrase: "121-124"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bannister,"

Phrase: "A."
Processing 00000000.tx.336: J., Cook, A., and Kouzarides, T. 

Phrase: "J.,"

Phrase: "Cook,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0335326:Cook [Daily or Recreational Activity]
  1000   C1306756:Cook [Professional or Occupational Group]

Phrase: "A.,"

Phrase: "and"

Phrase: "Kouzarides,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.337: (1991) Oncogene 6, 1243-1250 [Medline] [OrderarticleviaInfotrieve] Xanthoudakis, S., Mioa, G., Wang, F., Pan, Y.-C. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Oncogene 6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "1243-1250"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Xanthoudakis,"

Phrase: "S."

Phrase: ","

Phrase: "Mioa,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Wang,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Pan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085999:Pan [Mammal]

Phrase: "Y.-C."
Processing 00000000.tx.338: E., and Curran, T. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Curran,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.339: (1992) EMBO J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.340: 11, 3323-3335 [Abstract] Ammendola, R., Mesuraca, M., Russo, T., and Cimino, F. 

Phrase: "11,"

Phrase: "3323-3335"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ammendola,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mesuraca,"

Phrase: "M."

Phrase: ","

Phrase: "Russo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Cimino,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.341: (1994) Eur. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.342: J.

Phrase: "J."
Processing 00000000.tx.343: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.344: 225, 483-489 [Abstract] Yoshimori, T., Semba, T., Takemoto, H., Akagi, S., Yamamoto, A., and Tashiro, Y. 

Phrase: "225,"

Phrase: "483-489"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Yoshimori,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Semba,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takemoto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Akagi,"

Phrase: "S."

Phrase: ","

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "A.,"

Phrase: "and"

Phrase: "Tashiro,"

Phrase: "Y."
Processing 00000000.tx.345: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.346: Biol. 

Phrase: "Biol."
Processing 00000000.tx.347: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.348: 265, 15984-15990 [Abstract/Free FullText] Martin, H., and Dean, M. 

Phrase: "265,"

Phrase: "15984-15990"

Phrase: "[Abstract/Free FullText"

Phrase: "] Martin,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Dean,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.349: (1991) Biochem. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.350: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.351: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.352: Commun. 

Phrase: "Commun."
Processing 00000000.tx.353: 175, 123-128 [Medline] [OrderarticleviaInfotrieve] Terada, K., Manchikalapudi, P., Noiva, R., Jauregui, H. 

Phrase: "175,"

Phrase: "123-128"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Terada,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Manchikalapudi,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Noiva,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Jauregui,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.354: O., Stockert, R. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Stockert,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.355: J., and Schilsky, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Schilsky,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.356: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.357: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.358: Biol. 

Phrase: "Biol."
Processing 00000000.tx.359: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.360: 270, 20410-20416 [Abstract/Free FullText] 1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "270,"

Phrase: "20410-20416"

Phrase: "[Abstract/Free FullText"

Phrase: "] 1997 by The American Society"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037455:society [Organization]
   760   C0596070:American [Population Group]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

